<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd"><opensearch:totalResults>6422959</opensearch:totalResults><opensearch:startIndex>0</opensearch:startIndex><opensearch:itemsPerPage>25</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="all(gene)" startPage="0"/><link ref="self" href="https://api.elsevier.com/content/search/scopus?start=0&amp;count=25&amp;query=all%28gene%29&amp;apiKey=7f59af901d2d86f78a1fd60c1bf9426a&amp;view=complete" type="application/xml"/><link ref="first" href="https://api.elsevier.com/content/search/scopus?start=0&amp;count=25&amp;query=all%28gene%29&amp;apiKey=7f59af901d2d86f78a1fd60c1bf9426a&amp;view=complete" type="application/xml"/><link ref="next" href="https://api.elsevier.com/content/search/scopus?start=25&amp;count=25&amp;query=all%28gene%29&amp;apiKey=7f59af901d2d86f78a1fd60c1bf9426a&amp;view=complete" type="application/xml"/><link ref="last" href="https://api.elsevier.com/content/search/scopus?start=4975&amp;count=25&amp;query=all%28gene%29&amp;apiKey=7f59af901d2d86f78a1fd60c1bf9426a&amp;view=complete" type="application/xml"/><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85062565024"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85062565024?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85062565024&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85062565024&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85062565024</prism:url><dc:identifier>SCOPUS_ID:85062565024</dc:identifier><eid>2-s2.0-85062565024</eid><dc:title>Optimization Problem of k-NN Classifier in DNA Microarray Methods</dc:title><dc:creator>Bentkowska U.</dc:creator><prism:publicationName>Studies in Fuzziness and Soft Computing</prism:publicationName><prism:issn>14349922</prism:issn><prism:volume>378</prism:volume><prism:pageRange>107-120</prism:pageRange><prism:coverDate>2020-01-01</prism:coverDate><prism:coverDisplayDate>2020</prism:coverDisplayDate><prism:doi>10.1007/978-3-030-12927-9_5</prism:doi><dc:description>© 2020, Springer Nature Switzerland AG. The microarrays are a particularly interesting tool in modern molecular biology, not only because of the wide spectrum of applications such as analysis of the genome structure, profile gene expression, genotyping, sequencing, but also due to the possibility of testing a large number of objects in one experiment (cf. [1, 2]). However, the identification of relevant information from a huge amount of data obtained using microarrays requires the use of sophisticated bioinformatic methods. Clustering methods or machine learning algorithms are applied. However, when such methods are used, there is a problem of lowering their performance on test data due to the large number of attributes (columns). In this chapter microarray methods are applied for identification of marker genes. Our aim is to show that the quality of classification in the case of large number of attributes may be improved while using the microarray methods and interval modeling. There will be considered the so called vertical decomposition of a table representing a given data set.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60007672</affiliation-url><afid>60007672</afid><affilname>University of Rzeszów</affilname><affiliation-city>Rzeszow</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Book Series</prism:aggregationType><subtype>ch</subtype><subtypeDescription>Chapter</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/56488042400</author-url><authid>56488042400</authid><authname>Bentkowska U.</authname><surname>Bentkowska</surname><given-name>Urszula</given-name><initials>U.</initials><afid>60007672</afid></author><source-id>4900152704</source-id><fund-no>undefined</fund-no><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85061342373"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85061342373?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85061342373&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85061342373&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85061342373</prism:url><dc:identifier>SCOPUS_ID:85061342373</dc:identifier><eid>2-s2.0-85061342373</eid><dc:title>Grey wolf optimizer: Theory, literature review, and application in computational fluid dynamics problems</dc:title><dc:creator>Mirjalili S.</dc:creator><prism:publicationName>Studies in Computational Intelligence</prism:publicationName><prism:issn>1860949X</prism:issn><prism:volume>811</prism:volume><prism:pageRange>87-105</prism:pageRange><prism:coverDate>2020-01-01</prism:coverDate><prism:coverDisplayDate>2020</prism:coverDisplayDate><prism:doi>10.1007/978-3-030-12127-3_6</prism:doi><dc:description>© Springer Nature Switzerland AG 2020. This chapter first discusses inspirations, methematicam models, and an in-depth literature of the recently proposed Grey Wolf Optimizer (GWO). Then, several experiments are conducted to analyze and benchmark the performance of different variants and improvements of this algorithm. The chapter also investigates the application of the GWO variants in finding an optimal design for a ship propeller.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60032987</affiliation-url><afid>60032987</afid><affilname>Griffith University</affilname><affiliation-city>Brisbane</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60064180</affiliation-url><afid>60064180</afid><affilname>The University of Jordan</affilname><affiliation-city>Amman</affiliation-city><affiliation-country>Jordan</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60072735</affiliation-url><afid>60072735</afid><affilname>Birzeit University</affilname><affiliation-city>Birzeit</affiliation-city><affiliation-country>Palestine</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60022927</affiliation-url><afid>60022927</afid><affilname>University of Tehran</affilname><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Book Series</prism:aggregationType><subtype>ch</subtype><subtypeDescription>Chapter</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/51461922300</author-url><authid>51461922300</authid><authname>Mirjalili S.</authname><surname>Mirjalili</surname><given-name>Seyedali</given-name><initials>S.</initials><afid>60032987</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/36766902800</author-url><authid>36766902800</authid><authname>Aljarah I.</authname><surname>Aljarah</surname><given-name>Ibrahim</given-name><initials>I.</initials><afid>60064180</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/52164079800</author-url><authid>52164079800</authid><authname>Mafarja M.</authname><surname>Mafarja</surname><given-name>Majdi</given-name><initials>M.</initials><afid>60072735</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/56541062900</author-url><authid>56541062900</authid><authname>Heidari A.</authname><surname>Heidari</surname><given-name>Ali Asghar</given-name><initials>A.A.</initials><afid>60022927</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/56962785300</author-url><authid>56962785300</authid><authname>Faris H.</authname><surname>Faris</surname><given-name>Hossam</given-name><initials>H.</initials><afid>60064180</afid></author><source-id>4900152708</source-id><fund-no>undefined</fund-no><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85061300924"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85061300924?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85061300924&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85061300924&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85061300924</prism:url><dc:identifier>SCOPUS_ID:85061300924</dc:identifier><eid>2-s2.0-85061300924</eid><dc:title>Dragonfly algorithm: Theory, literature review, and application in feature selection</dc:title><dc:creator>Mafarja M.</dc:creator><prism:publicationName>Studies in Computational Intelligence</prism:publicationName><prism:issn>1860949X</prism:issn><prism:volume>811</prism:volume><prism:pageRange>47-67</prism:pageRange><prism:coverDate>2020-01-01</prism:coverDate><prism:coverDisplayDate>2020</prism:coverDisplayDate><prism:doi>10.1007/978-3-030-12127-3_4</prism:doi><dc:description>© Springer Nature Switzerland AG 2020. In this chapter, a wrapper-based feature selection algorithm is designed and substantiated based on the binary variant of Dragonfly Algorithm (BDA). DA is a successful, well-established metaheuristic that revealed superior efficacy in dealing with various optimization problems including feature selection. In this chapter we are going first present the inspirations and methamatical modeds of DA in details. Then, the performance of this algorithm is tested on a special type of datasets that contain a huge number of features with low number of samples. This type of datasets makes the optimization process harder, because of the large search space, and the lack of adequate samples to train the model. The experimental results showed the ability of DA to deal with this type of datasets better than other optimizers in the literature. Moreover, an extensive literature review for the DA is provided in this chapter.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60072735</affiliation-url><afid>60072735</afid><affilname>Birzeit University</affilname><affiliation-city>Birzeit</affiliation-city><affiliation-country>Palestine</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60022927</affiliation-url><afid>60022927</afid><affilname>University of Tehran</affilname><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60064180</affiliation-url><afid>60064180</afid><affilname>The University of Jordan</affilname><affiliation-city>Amman</affiliation-city><affiliation-country>Jordan</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60032987</affiliation-url><afid>60032987</afid><affilname>Griffith University</affilname><affiliation-city>Brisbane</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Book Series</prism:aggregationType><subtype>ch</subtype><subtypeDescription>Chapter</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/52164079800</author-url><authid>52164079800</authid><authname>Mafarja M.</authname><surname>Mafarja</surname><given-name>Majdi</given-name><initials>M.</initials><afid>60072735</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/56541062900</author-url><authid>56541062900</authid><authname>Heidari A.</authname><surname>Heidari</surname><given-name>Ali Asghar</given-name><initials>A.A.</initials><afid>60022927</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/56962785300</author-url><authid>56962785300</authid><authname>Faris H.</authname><surname>Faris</surname><given-name>Hossam</given-name><initials>H.</initials><afid>60064180</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/51461922300</author-url><authid>51461922300</authid><authname>Mirjalili S.</authname><surname>Mirjalili</surname><given-name>Seyedali</given-name><initials>S.</initials><afid>60032987</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/36766902800</author-url><authid>36766902800</authid><authname>Aljarah I.</authname><surname>Aljarah</surname><given-name>Ibrahim</given-name><initials>I.</initials><afid>60064180</afid></author><source-id>4900152708</source-id><fund-no>undefined</fund-no><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85059166422"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85059166422?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85059166422&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85059166422&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85059166422</prism:url><dc:identifier>SCOPUS_ID:85059166422</dc:identifier><eid>2-s2.0-85059166422</eid><dc:title>Design of graphene-based adsorbents and its removal of antibiotics in aqueous solution</dc:title><dc:creator>Jiang Z.</dc:creator><prism:publicationName>Wuli Huaxue Xuebao/ Acta Physico - Chimica Sinica</prism:publicationName><prism:issn>10006818</prism:issn><prism:volume>35</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>709-724</prism:pageRange><prism:coverDate>2019-12-21</prism:coverDate><prism:coverDisplayDate>21 December 2019</prism:coverDisplayDate><prism:doi>10.3866/PKU.WHXB201807051</prism:doi><dc:description>© Editorial office of Acta Physico-Chimica Sinica. It is a widespread concern that the extensive use of antibiotics has caused not only harm to the human body but also heavy environmental pollution. Because of its high efficiency and universal applicability, adsorption technology has significant application potential for the removal of antibiotics. The development of new adsorbents is critical for high-efficiency adsorption treatment. In recent years, the excellent physical, chemical, and adsorption properties of graphene have made it an important antibiotic adsorbent. The high specific surface area and large number of pores of graphene provide many adsorption sites for antibiotics. In addition, the conjugated structure makes graphene relatively electronegative, which also affects adsorption. Due to the limitations of graphene and the increasing requirements for efficiency and stability of graphene adsorbents, a variety of graphene-based adsorbents have been developed to solve the issues of graphene agglomeration in aqueous solutions, poor graphene dispersibility, and poor adsorption performance. Thus far, there has not been a systematic review on the design, synthesis, and adsorption mechanism of graphene-based composites for the removal of antibiotics in aqueous solutions. The design and preparation methods for magnetic graphene adsorbents, polymer/graphene adsorbents, three-dimensional graphene gels, graphene/biochar adsorbents, and graphene-based adsorbents for catalytic degradation of antibiotics are also reviewed. We show the synthesis and design concepts of various graphene-based adsorbents, as well as their different physical and chemical properties and adsorption performance, so that we can distinguish and select different graphene-based adsorbents. We also discuss the design of adsorbents for different kinds of antibiotic contaminants to provide guidance to future researchers for choosing the appropriate design methods based on the antibiotic type. These graphene-based adsorbents can also be extended to the adsorption of various pollutants, which is of great significance for environmental protection. The main adsorption mechanism of antibiotics on graphene-based adsorbents in aqueous solutions is expounded. The cyclic structure of graphene determines the interaction between graphene and antibiotics, such as π–π and cation–π interactions. The numerous oxygen-containing functional groups on the surface of graphene oxide (GO) provide more possibilities for the design of graphene composites. Finally, the future development of graphene-based adsorbents for the removal of antibiotics in aqueous solutions is discussed. We recommend the design of highly-efficient, broad-spectrum, and selective adsorbents for high adsorption performance for multiple antibiotic contaminants in the environment. We also address the regeneration and disposal of graphene-based sorbents and promote green, harmless, and resource-based disposal.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60073652</affiliation-url><afid>60073652</afid><affilname>Tongji University</affilname><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60102070</affiliation-url><afid>60102070</afid><affilname>Shanghai Ocean University</affilname><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/120389671</affiliation-url><afid>120389671</afid><affilname>Shanghai Institute of Pollution Control and Ecological Security</affilname><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/57205219425</author-url><authid>57205219425</authid><authname>Jiang Z.</authname><surname>Jiang</surname><given-name>Zhe</given-name><initials>Z.</initials><afid>60073652</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57141396700</author-url><authid>57141396700</authid><authname>Yu F.</authname><surname>Yu</surname><given-name>Fei</given-name><initials>F.</initials><afid>60102070</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/55511070000</author-url><authid>55511070000</authid><authname>Ma J.</authname><surname>Ma</surname><given-name>Jie</given-name><initials>J.</initials><afid>60073652</afid><afid>120389671</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/55511070000</author-url><authid>55511070000</authid><authname>Ma J.</authname><surname>Ma</surname><given-name>Jie</given-name><initials>J.</initials><afid>60073652</afid><afid>120389671</afid></author><authkeywords>Adsorbent | Adsorption | Adsorption mechanism | Antibiotics | Graphene | Wastewater treatment</authkeywords><source-id>23773</source-id><fund-acr>NSFC</fund-acr><fund-no>21577099</fund-no><fund-sponsor>National Natural Science Foundation of China</fund-sponsor><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85045951305"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85045951305?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85045951305&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85045951305&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85045951305</prism:url><dc:identifier>SCOPUS_ID:85045951305</dc:identifier><eid>2-s2.0-85045951305</eid><dc:title>Contribution to the knowledge of the rare "famatina tuco-Tuco", Ctenomys famosus Thomas 1920 (Rodentia: Ctenomyidae)</dc:title><dc:creator>Tatiana Sánchez R.</dc:creator><prism:publicationName>Mammalia</prism:publicationName><prism:issn>00251461</prism:issn><prism:eIssn>18641547</prism:eIssn><prism:volume>83</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>11-22</prism:pageRange><prism:coverDate>2019-12-19</prism:coverDate><prism:coverDisplayDate>19 December 2019</prism:coverDisplayDate><prism:doi>10.1515/mammalia-2017-0131</prism:doi><dc:description>© 2019 Walter de Gruyter GmbH, Berlin/Boston 2019. Ctenomys famosus is one of the less known species of the genus, both in systematic and in phylogenetic aspects, as well as in its distribution and natural history. So far the only known specimens of this species are those from the type series, collected at the two localities mentioned in the original description, in La Rioja province, Argentina. We here provide new information about the species as well as some comments about the type locality, and add a new point to its known geographical distribution. In addition, the capture of topotypes allowed us to add unpublished information on molecular, morphological and cranial variables of the species. The phylogenetic analysis of mitochondrial gene cytochrome b sequences positions C. famosus in the context of the existing phylogenetic hypotheses and proposals for the genus as belonging to the "mendocinus group". This information can serve as a basis for future research that favors clarifying the evolutionary panorama of the group at the regional level, as well as for completing the existing relationships within the complex of the Argentine species of the genus.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60003933</affiliation-url><afid>60003933</afid><affilname>Universidad Nacional de Tucuman (UNT)</affilname><affiliation-city>San Miguel de Tucuman</affiliation-city><affiliation-country>Argentina</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/106587887</affiliation-url><afid>106587887</afid><affilname>Facultad de Ciencias</affilname><affiliation-city>Montevideo</affiliation-city><affiliation-country>Uruguay</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60023276</affiliation-url><afid>60023276</afid><affilname>Fundacion Miguel Lillo</affilname><affiliation-city>San Miguel de Tucuman</affiliation-city><affiliation-country>Argentina</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/57201727948</author-url><authid>57201727948</authid><authname>Tatiana Sánchez R.</authname><surname>Tatiana Sánchez</surname><given-name>R.</given-name><initials>R.</initials><afid>60003933</afid><afid>60023276</afid></author><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/57201727948</author-url><authid>57201727948</authid><authname>Tatiana Sánchez R.</authname><surname>Tatiana Sánchez</surname><given-name>R.</given-name><initials>R.</initials><afid>60003933</afid><afid>60023276</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57201723658</author-url><authid>57201723658</authid><authname>Ivanna Tomasco H.</authname><surname>Ivanna Tomasco</surname><given-name>H.</given-name><initials>H.</initials><afid>60003933</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/6505715685</author-url><authid>6505715685</authid><authname>Mónica Díaz M.</authname><surname>Mónica Díaz</surname><given-name>M.</given-name><initials>M.</initials><afid>106587887</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/6603651384</author-url><authid>6603651384</authid><authname>Barquez R.</authname><surname>Barquez</surname><given-name>Rubén M.</given-name><initials>R.M.</initials><afid>60023276</afid></author><authkeywords>cytochrome b | Famatina Chain | geographic distribution | La Rioja | type locality</authkeywords><source-id>22653</source-id><fund-no>undefined</fund-no><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85046080807"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85046080807?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85046080807&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85046080807&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85046080807</prism:url><dc:identifier>SCOPUS_ID:85046080807</dc:identifier><eid>2-s2.0-85046080807</eid><dc:title>Difficulty in visual sex identification: A case study on bank voles</dc:title><dc:creator>Bartolommei P.</dc:creator><prism:publicationName>Mammalia</prism:publicationName><prism:issn>00251461</prism:issn><prism:eIssn>18641547</prism:eIssn><prism:volume>83</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>70-73</prism:pageRange><prism:coverDate>2019-12-19</prism:coverDate><prism:coverDisplayDate>19 December 2019</prism:coverDisplayDate><prism:doi>10.1515/mammalia-2017-0170</prism:doi><dc:description>© 2019 Walter de Gruyter GmbH, Berlin/Boston 2019. The present study aims at quantifying the error in visual sexing of live-Trapped bank voles and evaluating if animal body weight and experience of field workers affected the ability to determine the sex of voles. The error in sex attribution involved 25.6% of non-reproductive individuals, pointing out the need to validate the field sex identification. Body weight of voles did not affect the ability of trappers to visually discriminate the sex of animals. Field workers had similar percentages of error independently of their expertise in vole sexing but they also showed a sex-bias in wrongly sexed individuals.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/112675221</affiliation-url><afid>112675221</afid><affilname>Fondazione Ethoikos</affilname><affiliation-city>Siena</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/121927771</affiliation-url><afid>121927771</afid><affilname>U.R. Ecologia Comportamentale</affilname><affiliation-city>Siena</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/21741930500</author-url><authid>21741930500</authid><authname>Bartolommei P.</authname><surname>Bartolommei</surname><given-name>Paola</given-name><initials>P.</initials><afid>112675221</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57140421500</author-url><authid>57140421500</authid><authname>Bencini C.</authname><surname>Bencini</surname><given-name>Cristina</given-name><initials>C.</initials><afid>112675221</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/56921932400</author-url><authid>56921932400</authid><authname>Bonacchi A.</authname><surname>Bonacchi</surname><given-name>Andrea</given-name><initials>A.</initials><afid>121927771</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/56921847300</author-url><authid>56921847300</authid><authname>Gasperini S.</authname><surname>Gasperini</surname><given-name>Stefania</given-name><initials>S.</initials><afid>112675221</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/36174200800</author-url><authid>36174200800</authid><authname>Manzo E.</authname><surname>Manzo</surname><given-name>Emiliano</given-name><initials>E.</initials><afid>112675221</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/6603671225</author-url><authid>6603671225</authid><authname>Cozzolino R.</authname><surname>Cozzolino</surname><given-name>Roberto</given-name><initials>R.</initials><afid>112675221</afid></author><authkeywords>genitalia observation | molecular sexing | Myodes glareolus | Rodentia | small mammal</authkeywords><source-id>22653</source-id><fund-no>undefined</fund-no><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060148885"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060148885?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060148885&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060148885&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060148885</prism:url><dc:identifier>SCOPUS_ID:85060148885</dc:identifier><eid>2-s2.0-85060148885</eid><dc:title>Cytotoxicity, dose-enhancement and radiosensitization of glioblastoma cells with rare earth nanoparticles</dc:title><dc:creator>Lu V.</dc:creator><prism:publicationName>Artificial Cells, Nanomedicine and Biotechnology</prism:publicationName><prism:issn>21691401</prism:issn><prism:eIssn>2169141X</prism:eIssn><prism:volume>47</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>132-143</prism:pageRange><prism:coverDate>2019-12-04</prism:coverDate><prism:coverDisplayDate>4 December 2019</prism:coverDisplayDate><prism:doi>10.1080/21691401.2018.1544564</prism:doi><dc:description>© 2019, © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor  &amp;  Francis Group.  Glioblastoma is a heterogeneous disease with multiple genotypic origins. Despite treatment protocols such as surgery, radiotherapy and chemotherapy, the prognosis for patients remains poor. This study investigates the cytotoxic and radiation dose-enhancing and radiosensitizing ability of five rare earth oxide nanoparticles, in two different immortalized mammalian cell lines; U-87 MG and Mo59K. Significant cytotoxicity was observed in U-87 MG cells when exposed to Nd 2 O 3 and La 2 O 3. Autophagy was also detected in cells after incubation with Nd 2 O 3. Radiosensitization was observed in U-87 MG when incubated with Gd 2 O 3 , CeO 2 -Gd and Nd 2 O 3 :Si. Importantly, these elements did not cause any intrinsic toxicity in the absence of irradiation and so could be considered biocompatible. The Gd 2 O 3 and CeO 2 -Gd nanoparticles were also seen to generate ROS in U-87 MG cells after irradiation. Furthermore, the Mo59K and U-87 MG cells responded very differently to exposure to the rare earth nanoparticles. This may indicate the importance of the genotype of cells in the successful use of rare earth oxides for treatment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60026851</affiliation-url><afid>60026851</afid><affilname>University of Oxford</affilname><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60026851</affiliation-url><afid>60026851</afid><affilname>University of Oxford</affilname><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60026851</affiliation-url><afid>60026851</afid><affilname>University of Oxford</affilname><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><pubmed-id>30663430</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/57205474376</author-url><authid>57205474376</authid><authname>Lu V.</authname><surname>Lu</surname><given-name>Victor M.</given-name><initials>V.M.</initials><afid>60026851</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57204916093</author-url><authid>57204916093</authid><authname>Crawshay-Williams F.</authname><surname>Crawshay-Williams</surname><given-name>Felicity</given-name><initials>F.</initials><afid>60026851</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/57201338145</author-url><authid>57201338145</authid><authname>White B.</authname><surname>White</surname><given-name>Benjamin</given-name><initials>B.</initials><afid>60026851</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57205476582</author-url><authid>57205476582</authid><authname>Elliot A.</authname><surname>Elliot</surname><given-name>Amy</given-name><initials>A.</initials><afid>60026851</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/7404447979</author-url><authid>7404447979</authid><authname>Hill M.</authname><surname>Hill</surname><given-name>Mark A.</given-name><initials>M.A.</initials><afid>60026851</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/6508215198</author-url><authid>6508215198</authid><authname>Townley H.</authname><surname>Townley</surname><given-name>Helen E.</given-name><initials>H.E.</initials><afid>60026851</afid><afid>60026851</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/6508215198</author-url><authid>6508215198</authid><authname>Townley H.</authname><surname>Townley</surname><given-name>Helen E.</given-name><initials>H.E.</initials><afid>60026851</afid><afid>60026851</afid></author><authkeywords>Glioblastoma | nanoparticle | oncology | radiotherapy | rare earth</authkeywords><source-id>21100241807</source-id><fund-no>MC-PC-12004</fund-no><fund-sponsor>Williams</fund-sponsor><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060135656"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060135656?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060135656&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060135656&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060135656</prism:url><dc:identifier>SCOPUS_ID:85060135656</dc:identifier><eid>2-s2.0-85060135656</eid><dc:title>In-vitro haemocompatibility of dextran-protein submicron particles</dc:title><dc:creator>Kloypan C.</dc:creator><prism:publicationName>Artificial Cells, Nanomedicine and Biotechnology</prism:publicationName><prism:issn>21691401</prism:issn><prism:eIssn>2169141X</prism:eIssn><prism:volume>47</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>241-249</prism:pageRange><prism:coverDate>2019-12-04</prism:coverDate><prism:coverDisplayDate>4 December 2019</prism:coverDisplayDate><prism:doi>10.1080/21691401.2018.1548476</prism:doi><dc:description>© 2019, © 2019 Informa UK Limited, trading as Taylor  &amp;  Francis Group. Blood compatibility is a key requirement to fulfil for intravenous administration of drug and oxygen carrier system. Recently, we published the fabrication of oxidised-dextran (Odex)-crosslinked protein particles by one-pot formulation. In the current study we investigate the haemocompatibility of these Odex - particles including albumin particles (Odex-APs) and haemoglobin particles (Odex-HbMPs). Odex-APs and Odex-HbMPs have a submicron size ranged 800–1000 nm with peanut-like shape and a negative surface charge. In vitro haemocompatibility assays included haemolysis test, indirect phagocytosis test and platelet activation test in human blood. Odex-APs and Odex-HbMPs did not provoke any undesirable effects on the blood cells. Firstly, the ratio of haemolysis after contacted with Odex-crosslinked protein particles were less than 5% and therefore the particles may be considered non-haemolytic. Secondly, the incubation of leukocyte with Odex-APs/HbMPs did not influence the phagocytosis of leukocyte. We conclude that our particles are not recognized by monocytes or granulocytes. Finally, exposure of Odex-APs/HbMPs to platelets did not cause an activation of platelets. Additionally, Odex-HbMP/AP did not enhance or attenuate agonist-induced platelet activation. We conclude that Odex-crosslinked protein particles exhibit a very good haemocompatibility and represent highly promising carriers for drugs or oxygen.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60026245</affiliation-url><afid>60026245</afid><affilname>Charité – Universitätsmedizin Berlin</affilname><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60114221</affiliation-url><afid>60114221</afid><affilname>University of Phayao</affilname><affiliation-city>Phayao</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60114221</affiliation-url><afid>60114221</afid><affilname>University of Phayao</affilname><affiliation-city>Phayao</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60022498</affiliation-url><afid>60022498</afid><affilname>Naresuan University</affilname><affiliation-city>Pitsanulok</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60006387</affiliation-url><afid>60006387</afid><affilname>Payap University</affilname><affiliation-city>Chiangmai</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60114221</affiliation-url><afid>60114221</afid><affilname>University of Phayao</affilname><affiliation-city>Phayao</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60012784</affiliation-url><afid>60012784</afid><affilname>Trakia University</affilname><affiliation-city>Stara Zagora</affiliation-city><affiliation-country>Bulgaria</affiliation-country></affiliation><pubmed-id>30663396</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55188527100</author-url><authid>55188527100</authid><authname>Kloypan C.</authname><surname>Kloypan</surname><given-name>Chiraphat</given-name><initials>C.</initials><afid>60026245</afid><afid>60114221</afid></author><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55188527100</author-url><authid>55188527100</authid><authname>Kloypan C.</authname><surname>Kloypan</surname><given-name>Chiraphat</given-name><initials>C.</initials><afid>60026245</afid><afid>60114221</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57204549844</author-url><authid>57204549844</authid><authname>Suwannasom N.</authname><surname>Suwannasom</surname><given-name>Nittiya</given-name><initials>N.</initials><afid>60026245</afid><afid>60114221</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57204549844</author-url><authid>57204549844</authid><authname>Suwannasom N.</authname><surname>Suwannasom</surname><given-name>Nittiya</given-name><initials>N.</initials><afid>60026245</afid><afid>60114221</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/57204549092</author-url><authid>57204549092</authid><authname>Chaiwaree S.</authname><surname>Chaiwaree</surname><given-name>Saranya</given-name><initials>S.</initials><afid>60022498</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57204546459</author-url><authid>57204546459</authid><authname>Prapan A.</authname><surname>Prapan</surname><given-name>Ausanai</given-name><initials>A.</initials><afid>60006387</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/55871862100</author-url><authid>55871862100</authid><authname>Smuda K.</authname><surname>Smuda</surname><given-name>Kathrin</given-name><initials>K.</initials><afid>60026245</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/55630412100</author-url><authid>55630412100</authid><authname>Baisaeng N.</authname><surname>Baisaeng</surname><given-name>Nuttakorn</given-name><initials>N.</initials><afid>60114221</afid></author><author seq="7"><author-url>https://api.elsevier.com/content/author/author_id/24400140300</author-url><authid>24400140300</authid><authname>Pruß A.</authname><surname>Pruß</surname><given-name>Axel</given-name><initials>A.</initials><afid>60026245</afid></author><author seq="8"><author-url>https://api.elsevier.com/content/author/author_id/7007064334</author-url><authid>7007064334</authid><authname>Georgieva R.</authname><surname>Georgieva</surname><given-name>Radostina</given-name><initials>R.</initials><afid>60026245</afid><afid>60012784</afid></author><author seq="8"><author-url>https://api.elsevier.com/content/author/author_id/7007064334</author-url><authid>7007064334</authid><authname>Georgieva R.</authname><surname>Georgieva</surname><given-name>Radostina</given-name><initials>R.</initials><afid>60026245</afid><afid>60012784</afid></author><author seq="9"><author-url>https://api.elsevier.com/content/author/author_id/7003439827</author-url><authid>7003439827</authid><authname>Bäumler H.</authname><surname>Bäumler</surname><given-name>Hans</given-name><initials>H.</initials><afid>60026245</afid></author><authkeywords>dextran | Haemocompatibility | hemoglobin | submicron particles</authkeywords><source-id>21100241807</source-id><fund-no>undefined</fund-no><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060164297"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060164297?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060164297&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060164297&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060164297</prism:url><dc:identifier>SCOPUS_ID:85060164297</dc:identifier><eid>2-s2.0-85060164297</eid><dc:title>Biotin-functionalized copolymeric PEG-PCL micelles for in vivo tumour-targeted delivery of artemisinin</dc:title><dc:creator>Nosrati H.</dc:creator><prism:publicationName>Artificial Cells, Nanomedicine and Biotechnology</prism:publicationName><prism:issn>21691401</prism:issn><prism:eIssn>2169141X</prism:eIssn><prism:volume>47</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>104-114</prism:pageRange><prism:coverDate>2019-12-04</prism:coverDate><prism:coverDisplayDate>4 December 2019</prism:coverDisplayDate><prism:doi>10.1080/21691401.2018.1543199</prism:doi><dc:description>© 2019, © 2019 Informa UK Limited, trading as Taylor  &amp;  Francis Group. Artemisinin is used as an antimalarial and anticancer agent with minimal toxic effects on the host body. Biotin-PEG-PCL polymers have been used for targeted drug delivery to cancer, as well as to improve the pharmacokinetics of the drug and reduce its effects. In this study, biotin-conjugated copolymers were fabricated with polymerization of the ring opening method and the properties of copolymer and nanoparticles were investigated using various techniques. The toxicity of artemisinin and its nanoparticles have been investigated on MCF-7 and normal HFF2 cells. The results showed that the encapsulation efficacy of artemisinin in nanoparticles was 45.5 ± 0.41%. The release profile of the drug indicates that the release is slow and controlled and is approximately pH dependent. The results of artemisinin cell culture on human breast cancer cells showed that biotin-PEG-PCL nanoparticles had an inhibitory effect on MCF-7 cells and had no toxic effects on HFF2 cells. Anticancer activity in vivo in the 4T1 breast cancer model showed that tumour volumes were decreased up 40 mm3 by ART-loaded micelles and 76 mm3 by free ART, compared to the control group (2150 mm). In vivo results showed that this formulation significantly increases the accumulation of substances in the tumours. Therefore, the molecular formulation of ART-based copolymers can be a desirable process for cancer treatment purposes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60012874</affiliation-url><afid>60012874</afid><affilname>Zanjan University of Medical Sciences</affilname><affiliation-city>Zanjan</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60012874</affiliation-url><afid>60012874</afid><affilname>Zanjan University of Medical Sciences</affilname><affiliation-city>Zanjan</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60012874</affiliation-url><afid>60012874</afid><affilname>Zanjan University of Medical Sciences</affilname><affiliation-city>Zanjan</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60012874</affiliation-url><afid>60012874</afid><affilname>Zanjan University of Medical Sciences</affilname><affiliation-city>Zanjan</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><pubmed-id>30663422</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55945532400</author-url><authid>55945532400</authid><authname>Nosrati H.</authname><surname>Nosrati</surname><given-name>Hamed</given-name><initials>H.</initials><afid>60012874</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57205463530</author-url><authid>57205463530</authid><authname>Barzegari P.</authname><surname>Barzegari</surname><given-name>Parisa</given-name><initials>P.</initials><afid>60012874</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/57197860941</author-url><authid>57197860941</authid><authname>Danafar H.</authname><surname>Danafar</surname><given-name>Hossein</given-name><initials>H.</initials><afid>60012874</afid><afid>60012874</afid><afid>60012874</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/57197860941</author-url><authid>57197860941</authid><authname>Danafar H.</authname><surname>Danafar</surname><given-name>Hossein</given-name><initials>H.</initials><afid>60012874</afid><afid>60012874</afid><afid>60012874</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/57197860941</author-url><authid>57197860941</authid><authname>Danafar H.</authname><surname>Danafar</surname><given-name>Hossein</given-name><initials>H.</initials><afid>60012874</afid><afid>60012874</afid><afid>60012874</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57200197026</author-url><authid>57200197026</authid><authname>Kheiri Manjili H.</authname><surname>Kheiri Manjili</surname><given-name>Hamidreza</given-name><initials>H.</initials><afid>60012874</afid><afid>60012874</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57200197026</author-url><authid>57200197026</authid><authname>Kheiri Manjili H.</authname><surname>Kheiri Manjili</surname><given-name>Hamidreza</given-name><initials>H.</initials><afid>60012874</afid><afid>60012874</afid></author><authkeywords>anticancer | Artemisinin | biotin-PEG-PCL polymers | micelles | target drug delivery</authkeywords><source-id>21100241807</source-id><fund-acr>ZUMS</fund-acr><fund-no>A-12-430-19</fund-no><fund-sponsor>Zanjan University of Medical Sciences</fund-sponsor><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060137573"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060137573?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060137573&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060137573&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060137573</prism:url><dc:identifier>SCOPUS_ID:85060137573</dc:identifier><eid>2-s2.0-85060137573</eid><dc:title>Effect of exposure of osteoblast-like cells to low-dose silver nanoparticles: uptake, retention and osteogenic activity</dc:title><dc:creator>Xie H.</dc:creator><prism:publicationName>Artificial Cells, Nanomedicine and Biotechnology</prism:publicationName><prism:issn>21691401</prism:issn><prism:eIssn>2169141X</prism:eIssn><prism:volume>47</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>260-267</prism:pageRange><prism:coverDate>2019-12-04</prism:coverDate><prism:coverDisplayDate>4 December 2019</prism:coverDisplayDate><prism:doi>10.1080/21691401.2018.1552594</prism:doi><dc:description>© 2019, © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor  &amp;  Francis Group. Objective: Silver nanoparticles (AgNPs) are widely used in orthopaedic implants because of their excellent antimicrobial properties. However, the effects of AgNPs on bone cells and osteogenic activity are still poorly understood. Method: Here, we investigated the effect of AgNPs on the cell viability, uptake, and osteogenic activity of osteoblast-like cells (MG-63 cells) at low concentrations. Results: Our results showed that uptake and retention of AgNPs reduced the cell viability and increased cell membrane penetrability even after termination of exposure of MG-63 cells to AgNPs. In addition, AgNPs induced cell shrinkage, reduced the expressions of ALP, COL-I, OCN and OPG, and enhanced the expressions of Runx2 and RANKL. Conclusion: Collectively, our work demonstrated that the cytotoxic effects of low-dose AgNPs on MG-63 cells persisted even after termination of exposure. AgNPs may interfere with bone formation. More attention should be paid to the toxicity of AgNPs during the design of future orthopaedic implants.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/105741554</affiliation-url><afid>105741554</afid><affilname>Linyi People’s Hospital</affilname><affiliation-city>Linyi</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/112234216</affiliation-url><afid>112234216</afid><affilname>Tianjin Fourth Central Hospital</affilname><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/106283585</affiliation-url><afid>106283585</afid><affilname>Shandong Medical College</affilname><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><pubmed-id>30663398</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/57207263826</author-url><authid>57207263826</authid><authname>Xie H.</authname><surname>Xie</surname><given-name>Hongjun</given-name><initials>H.</initials><afid>105741554</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57205472235</author-url><authid>57205472235</authid><authname>Wang P.</authname><surname>Wang</surname><given-name>Pei</given-name><initials>P.</initials><afid>112234216</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/57206989253</author-url><authid>57206989253</authid><authname>Wu J.</authname><surname>Wu</surname><given-name>Jie</given-name><initials>J.</initials><afid>106283585</afid></author><authkeywords>low-dose exposure | MG-63 cells | retention | Silver nanoparticles | uptake</authkeywords><source-id>21100241807</source-id><fund-no>ZR2017MH108</fund-no><fund-sponsor>Natural Science Foundation of Shandong Province</fund-sponsor><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060128010"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060128010?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060128010&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060128010&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060128010</prism:url><dc:identifier>SCOPUS_ID:85060128010</dc:identifier><eid>2-s2.0-85060128010</eid><dc:title>Riboflavin immobilized Fe&lt;inf&gt;3&lt;/inf&gt;O&lt;inf&gt;4&lt;/inf&gt; magnetic nanoparticles carried with n-butylidenephthalide as targeting-based anticancer agents</dc:title><dc:creator>Wu C.</dc:creator><prism:publicationName>Artificial Cells, Nanomedicine and Biotechnology</prism:publicationName><prism:issn>21691401</prism:issn><prism:eIssn>2169141X</prism:eIssn><prism:volume>47</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>210-220</prism:pageRange><prism:coverDate>2019-12-04</prism:coverDate><prism:coverDisplayDate>4 December 2019</prism:coverDisplayDate><prism:doi>10.1080/21691401.2018.1548473</prism:doi><dc:description>© 2019, © 2019 The Author(s). Informa UK Limited, trading as Taylor  &amp;  Francis Group. n-Butylidenephthalide (BP) is a potential anti-cancer drug, which can be extracted from Angelica sinensis (Danggui). Previous reports have shown the effectiveness of BP in treating cancer diseases. However, BP has no targeting capacity towards specific cancer cells. To improve treatment efficiency and reduce the dose of BP used in cancer treatment, targeting-based approaches should be developed. In the present study, we used riboflavin-5′-phosphate (RFMP) immobilized iron oxide magnetic nanoparticles (Fe3O4 MNPs) as carriers for BP to treat cancer cell lines derived from liver, prostate and breast. These model cancer cells overexpress riboflavin receptors on their cell membrane and are also sensitive to BP treatment. Thus, BP-binding free RFMP on MNPs can be used as probes to target these model cells, whereas BP can be readily released on target cancer cells. Cell viability was twofold lower by using Fe3O4@RFMP MNPs immobilized with BP than that achieved by using free-form BP at a similar amount. Moreover, BP-Fe3O4@RFMP MNPs have no apparent harmful effects on non-target cells. In addition, we evaluated the level of cysteine-aspartic acid protease 3 (caspase 3) in the resultant cell lysate obtained after treatment by BP-Fe3O4@RFMP MNPs to demonstrate that apoptosis is mainly involved in the growth inhibition of target cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60012370</affiliation-url><afid>60012370</afid><affilname>National Chiao Tung University Taiwan</affilname><affiliation-city>Hsin-chu</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><pubmed-id>30663404</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/57201887813</author-url><authid>57201887813</authid><authname>Wu C.</authname><surname>Wu</surname><given-name>Ching Yi</given-name><initials>C.Y.</initials><afid>60012370</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/35236177100</author-url><authid>35236177100</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yu Chie</given-name><initials>Y.C.</initials><afid>60012370</afid></author><authkeywords>Angelica sinensis | anticancer | drug delivery | iron oxide magnetic nanoparticles | n-Butylidenephthalide | riboflavin</authkeywords><source-id>21100241807</source-id><fund-acr>MOST</fund-acr><fund-no>105-2113-M-009-022-MY3</fund-no><fund-sponsor>Ministry of Science and Technology, Taiwan</fund-sponsor><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060576613"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060576613?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060576613&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060576613&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060576613</prism:url><dc:identifier>SCOPUS_ID:85060576613</dc:identifier><eid>2-s2.0-85060576613</eid><dc:title>Gold nanoparticles and hepatitis B virus</dc:title><dc:creator>Negahdari B.</dc:creator><prism:publicationName>Artificial Cells, Nanomedicine and Biotechnology</prism:publicationName><prism:issn>21691401</prism:issn><prism:eIssn>2169141X</prism:eIssn><prism:volume>47</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>469-474</prism:pageRange><prism:coverDate>2019-12-04</prism:coverDate><prism:coverDisplayDate>4 December 2019</prism:coverDisplayDate><prism:doi>10.1080/21691401.2018.1546185</prism:doi><dc:description>© 2019 The Author(s). Hepatitis B virus (HBV) infection is one of the major health issues in the world presently with high tendency of leading to hepatocarcinoma, cirrhosis and liver cancer, especially if not properly managed. It has been estimated that there are about 2 billion people with a serological profile of HBV infection, and 360 million patients worldwide living with chronic HBV-associated liver disease, hence the need to find an efficient and precise diagnosis technique to drive a robust treatment for Hepatitis B virus cannot be over emphasized. The emergence of analytical device like biosensor which combines biological and physicochemical element to detect HBV in screened samples has been very helpful in providing a timely intervention to tame this virus. This review focuses on the current state of biosensor researches with respect to various in-depth application of gold nanoparticle for the detection of HBV.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60027708</affiliation-url><afid>60027708</afid><affilname>Tehran University of Medical Sciences</affilname><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60027708</affiliation-url><afid>60027708</afid><affilname>Tehran University of Medical Sciences</affilname><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60105206</affiliation-url><afid>60105206</afid><affilname>Aja University of Medical Sciences</affilname><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><pubmed-id>30686057</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55918361200</author-url><authid>55918361200</authid><authname>Negahdari B.</authname><surname>Negahdari</surname><given-name>Babak</given-name><initials>B.</initials><afid>60027708</afid><afid>60027708</afid></author><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55918361200</author-url><authid>55918361200</authid><authname>Negahdari B.</authname><surname>Negahdari</surname><given-name>Babak</given-name><initials>B.</initials><afid>60027708</afid><afid>60027708</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/56556424400</author-url><authid>56556424400</authid><authname>Darvishi M.</authname><surname>Darvishi</surname><given-name>Mohammad</given-name><initials>M.</initials><afid>60105206</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/54889964900</author-url><authid>54889964900</authid><authname>Saeedi A.</authname><surname>Saeedi</surname><given-name>Ali Asghar</given-name><initials>A.A.</initials><afid>60105206</afid></author><authkeywords>Biosensor | Gold nanoparticle | Hepatitis B virus</authkeywords><source-id>21100241807</source-id><fund-no>undefined</fund-no><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060159867"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060159867?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060159867&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060159867&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060159867</prism:url><dc:identifier>SCOPUS_ID:85060159867</dc:identifier><eid>2-s2.0-85060159867</eid><dc:title>Synthesis and characterization of PEG-functionalized graphene oxide as an effective pH-sensitive drug carrier</dc:title><dc:creator>Kazempour M.</dc:creator><prism:publicationName>Artificial Cells, Nanomedicine and Biotechnology</prism:publicationName><prism:issn>21691401</prism:issn><prism:eIssn>2169141X</prism:eIssn><prism:volume>47</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>90-94</prism:pageRange><prism:coverDate>2019-12-04</prism:coverDate><prism:coverDisplayDate>4 December 2019</prism:coverDisplayDate><prism:doi>10.1080/21691401.2018.1543196</prism:doi><dc:description>© 2019, © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor  &amp;  Francis Group. In the present work, PEG4000 as a hydrophilic polymer was conjugated to the surface of graphene oxide (GO) for effective drug loading and targeting release of doxorubicin. The synthesized nanohybrid was characterized with scanning electron microscope (SEM), X-ray diffraction spectroscopy (XRD) and Fourier-transformed infrared spectroscopy (FTIR). Doxorubicin as an anticancer drug was immobilized on the nanohybrid surface, and the release profile at two diverse pH besides the MTT assay was investigated. The IC50 value for the nanohybrid obtained was 0.31 μg/mL. In this work, PEG4000 as a biocompatible polymer grafted on the GO surface to increase the biodispersibility of the drug carrier in a biological environment, but it is the first report of PEG 4000-GO nanohybrid-based drug carrier.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60006622</affiliation-url><afid>60006622</afid><affilname>University of Tabriz</affilname><affiliation-city>Tabriz</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60006622</affiliation-url><afid>60006622</afid><affilname>University of Tabriz</affilname><affiliation-city>Tabriz</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60031210</affiliation-url><afid>60031210</afid><affilname>Tabriz University of Medical Sciences</affilname><affiliation-city>Tabriz</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><pubmed-id>30663418</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/57205474916</author-url><authid>57205474916</authid><authname>Kazempour M.</authname><surname>Kazempour</surname><given-name>Mohamad</given-name><initials>M.</initials><afid>60006622</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/6602623076</author-url><authid>6602623076</authid><authname>Namazi H.</authname><surname>Namazi</surname><given-name>Hassan</given-name><initials>H.</initials><afid>60006622</afid><afid>60006622</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/6602623076</author-url><authid>6602623076</authid><authname>Namazi H.</authname><surname>Namazi</surname><given-name>Hassan</given-name><initials>H.</initials><afid>60006622</afid><afid>60006622</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/36787804000</author-url><authid>36787804000</authid><authname>Akbarzadeh A.</authname><surname>Akbarzadeh</surname><given-name>Abolfazl</given-name><initials>A.</initials><afid>60031210</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/23489161700</author-url><authid>23489161700</authid><authname>Kabiri R.</authname><surname>Kabiri</surname><given-name>Roya</given-name><initials>R.</initials><afid>60006622</afid></author><authkeywords>doxorubicin | drug delivery | Graphene oxide | PEG 4000</authkeywords><source-id>21100241807</source-id><fund-no>undefined</fund-no><fund-sponsor>University of Tabriz</fund-sponsor><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060148231"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060148231?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060148231&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060148231&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060148231</prism:url><dc:identifier>SCOPUS_ID:85060148231</dc:identifier><eid>2-s2.0-85060148231</eid><dc:title>Fluorescent labelling in living dental pulp stem cells by graphene oxide quantum dots</dc:title><dc:creator>Li X.</dc:creator><prism:publicationName>Artificial Cells, Nanomedicine and Biotechnology</prism:publicationName><prism:issn>21691401</prism:issn><prism:eIssn>2169141X</prism:eIssn><prism:volume>47</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>115-122</prism:pageRange><prism:coverDate>2019-12-04</prism:coverDate><prism:coverDisplayDate>4 December 2019</prism:coverDisplayDate><prism:doi>10.1080/21691401.2018.1544141</prism:doi><dc:description>© 2019, © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor  &amp;  Francis Group. Cellular labelling is possible to offer significant information after transplantation for the purpose of determining stem cell therapy’s efficacy. According to the research, it has been reported that graphene oxide quantum dots (GOQDs) are a kind of healthy biological labelling agent for stem cells which show little cytotoxicity. GOQDs’ interactions have been examined on the dental pulp stem cells (hDPSCs) of human beings for the purpose of investigating GOQD’s biocompatibility and uptake and explored GOQDs’ effects on hDPSCs’ metabolic activity and the proliferation. According to the outcomes, GDQDs have been accepted by hDPSCs in a time-dependent and concentration-dependent behaviour. Moreover, no important changes have been discovered within hDOPSCs’ proliferation, viability as well as metabolic activity after treatment with GOQDs. Therefore, such resources have shown that GOQDs can be multifunctional agents for cell therapy, drug delivery as well as cell imaging and also as outstanding candidates for labelling stem cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60004667</affiliation-url><afid>60004667</afid><affilname>Nanjing University, School of Medicine</affilname><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60018310</affiliation-url><afid>60018310</afid><affilname>Nanjing Medical University</affilname><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60004667</affiliation-url><afid>60004667</afid><affilname>Nanjing University, School of Medicine</affilname><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60004667</affiliation-url><afid>60004667</afid><affilname>Nanjing University, School of Medicine</affilname><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><pubmed-id>30663424</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/57203927538</author-url><authid>57203927538</authid><authname>Li X.</authname><surname>Li</surname><given-name>Xincong</given-name><initials>X.</initials><afid>60004667</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57205474594</author-url><authid>57205474594</authid><authname>Guo H.</authname><surname>Guo</surname><given-name>Haowei</given-name><initials>H.</initials><afid>60018310</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/56176672000</author-url><authid>56176672000</authid><authname>Ren S.</authname><surname>Ren</surname><given-name>Shuangshuang</given-name><initials>S.</initials><afid>60004667</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57202247787</author-url><authid>57202247787</authid><authname>Fan R.</authname><surname>Fan</surname><given-name>Ruirui</given-name><initials>R.</initials><afid>60004667</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/56918878200</author-url><authid>56918878200</authid><authname>Yu Y.</authname><surname>Yu</surname><given-name>Yijun</given-name><initials>Y.</initials><afid>60004667</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/57197759489</author-url><authid>57197759489</authid><authname>Zhang H.</authname><surname>Zhang</surname><given-name>He</given-name><initials>H.</initials><afid>60004667</afid></author><author seq="7"><author-url>https://api.elsevier.com/content/author/author_id/56937353500</author-url><authid>56937353500</authid><authname>Liu C.</authname><surname>Liu</surname><given-name>Chao</given-name><initials>C.</initials><afid>60004667</afid></author><author seq="8"><author-url>https://api.elsevier.com/content/author/author_id/23094745000</author-url><authid>23094745000</authid><authname>Miao L.</authname><surname>Miao</surname><given-name>Leiying</given-name><initials>L.</initials><afid>60004667</afid></author><authkeywords>biocompatibility | Cellular labelling | graphene oxide quantum dot | photoluminescence</authkeywords><source-id>21100241807</source-id><fund-acr>NSFC</fund-acr><fund-no>undefined</fund-no><fund-sponsor>Natural Science Foundation of Jiangsu Province</fund-sponsor><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060184759"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060184759?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060184759&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060184759&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060184759</prism:url><dc:identifier>SCOPUS_ID:85060184759</dc:identifier><eid>2-s2.0-85060184759</eid><dc:title>Fabrication and evaluation a transferrin receptor targeting nano-drug carrier for cerebral infarction treatment</dc:title><dc:creator>Shen J.</dc:creator><prism:publicationName>Artificial Cells, Nanomedicine and Biotechnology</prism:publicationName><prism:issn>21691401</prism:issn><prism:eIssn>2169141X</prism:eIssn><prism:volume>47</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>192-200</prism:pageRange><prism:coverDate>2019-12-04</prism:coverDate><prism:coverDisplayDate>4 December 2019</prism:coverDisplayDate><prism:doi>10.1080/21691401.2018.1548471</prism:doi><dc:description>© 2019, © 2019 The Author(s). Informa UK Limited, trading as Taylor  &amp;  Francis Group. After cerebral infarction, the regeneration of microvascular played an important role in the recovery. Ginsenoside Rg1 (Rg1) had good effects on promoting angiogenesis and neuro-protection in cerebral infarction treatment. However, the blood-brain barrier (BBB) restricted Rg1 to enter into cerebral tissue. Transferrin receptor (TfR) was over-expressed in the BBB. In this study, we fabricated a TfR targeting nano-carrier (PATRC) to penetrate the BBB for treatment of cerebral infarction. A TfR targeted peptide was conjugated with the nano-carrier wrapped hydrophobic Rg1. The nanoscale size (132 ± 12 nm), polydispersity index (PDI =0.29) and the zeta potential (−38mv) were tested with dynamic light scattering optical system. Surface morphology (ellipse, mean diameter 122 ± 26 nm) was detected by transmission electron microscope (TEM). PATRC implement cell targeting ability on rat brain microvascular endothelial cells RBE4 in vitro detected by immunofluorescence and flow cytometry methods. Comparing with Rg1 threated group, the PATRC exhibited more prominent ability on the tube formation ability (p &lt;.05) in vitro. Comparing with the Rg1 treated group, PATRC penetrated BBB in vivo detected by HPLC, decreased the brain infarction volume tested with TTC staining and promoted regeneration of microvascular in infarction zone detected by CD31 immunofluorescence. PATRC has great potentiality for wide application in clinic.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60033100</affiliation-url><afid>60033100</afid><affilname>Nanjing University</affilname><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><pubmed-id>30663409</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/57195602640</author-url><authid>57195602640</authid><authname>Shen J.</authname><surname>Shen</surname><given-name>Junyi</given-name><initials>J.</initials><afid>60033100</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/55726170400</author-url><authid>55726170400</authid><authname>Zhao Z.</authname><surname>Zhao</surname><given-name>Zhiming</given-name><initials>Z.</initials><afid>60033100</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/57204451287</author-url><authid>57204451287</authid><authname>Shang W.</authname><surname>Shang</surname><given-name>Wei</given-name><initials>W.</initials><afid>60033100</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57195602519</author-url><authid>57195602519</authid><authname>Liu C.</authname><surname>Liu</surname><given-name>Chunli</given-name><initials>C.</initials><afid>60033100</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/57195600705</author-url><authid>57195600705</authid><authname>Zhang B.</authname><surname>Zhang</surname><given-name>Beibei</given-name><initials>B.</initials><afid>60033100</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/57202731354</author-url><authid>57202731354</authid><authname>Xu Z.</authname><surname>Xu</surname><given-name>Zihan</given-name><initials>Z.</initials><afid>60033100</afid></author><author seq="7"><author-url>https://api.elsevier.com/content/author/author_id/55650852300</author-url><authid>55650852300</authid><authname>Cai H.</authname><surname>Cai</surname><given-name>Hui</given-name><initials>H.</initials><afid>60033100</afid></author><authkeywords>blood-brain barrier | Cerebral infarction | ginsenoside Rg1 | transferrin receptor</authkeywords><source-id>21100241807</source-id><fund-acr>NSFC</fund-acr><fund-no>81273725</fund-no><fund-sponsor>National Natural Science Foundation of China</fund-sponsor><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85059175023"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85059175023?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85059175023&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85059175023&amp;origin=inward"/><link ref="full-text" href="https://api.elsevier.com/content/article/eid/1-s2.0-S0958166918302088"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85059175023</prism:url><dc:identifier>SCOPUS_ID:85059175023</dc:identifier><eid>2-s2.0-85059175023</eid><dc:title>Gene therapy for blood diseases</dc:title><dc:creator>Kohn D.</dc:creator><prism:publicationName>Current Opinion in Biotechnology</prism:publicationName><prism:issn>09581669</prism:issn><prism:eIssn>18790429</prism:eIssn><prism:volume>60</prism:volume><prism:pageRange>39-45</prism:pageRange><prism:coverDate>2019-12-01</prism:coverDate><prism:coverDisplayDate>December 2019</prism:coverDisplayDate><prism:doi>10.1016/j.copbio.2018.11.016</prism:doi><pii>S0958166918302088</pii><dc:description>© 2018 Elsevier Ltd Genetic diseases affecting proteins and cells composing the blood may be treated by gene therapy using gene addition or gene editing methods. Protein deficiencies (e.g. hemophilia) are being approached using in vivo gene delivery by adeno-associated virus (AAV) vectors for therapeutic gene addition or gene editing. Blood cell diseases (e.g. sickle cell disease) are being approached using ex vivo gene addition or gene editing to treat isolated blood-forming hematopoietic stem cells or T cells that are then re-transplanted. In recent years, there has been much progress, and gene therapy is now routinely providing clinical benefit to patients with a variety of conditions. Several of these gene therapies have been licensed in the U.S. and EU and more for other disorders are being advanced toward licensure. The scope of therapeutic activity for gene therapy is expected to continue to expand as the technical capabilities advance.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60005247</affiliation-url><afid>60005247</afid><affilname>David Geffen School of Medicine at UCLA</affilname><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60005247</affiliation-url><afid>60005247</afid><affilname>David Geffen School of Medicine at UCLA</affilname><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60005247</affiliation-url><afid>60005247</afid><affilname>David Geffen School of Medicine at UCLA</affilname><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/7201779643</author-url><authid>7201779643</authid><authname>Kohn D.</authname><surname>Kohn</surname><given-name>Donald B.</given-name><initials>D.B.</initials><afid>60005247</afid><afid>60005247</afid><afid>60005247</afid></author><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/7201779643</author-url><authid>7201779643</authid><authname>Kohn D.</authname><surname>Kohn</surname><given-name>Donald B.</given-name><initials>D.B.</initials><afid>60005247</afid><afid>60005247</afid><afid>60005247</afid></author><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/7201779643</author-url><authid>7201779643</authid><authname>Kohn D.</authname><surname>Kohn</surname><given-name>Donald B.</given-name><initials>D.B.</initials><afid>60005247</afid><afid>60005247</afid><afid>60005247</afid></author><source-id>15579</source-id><fund-acr>ADA</fund-acr><fund-no>undefined</fund-no><fund-sponsor>Doris Duke Charitable Foundation</fund-sponsor><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85062271791"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85062271791?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85062271791&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85062271791&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85062271791</prism:url><dc:identifier>SCOPUS_ID:85062271791</dc:identifier><eid>2-s2.0-85062271791</eid><dc:title>The Essentiality Status of Mouse Duplicate Gene Pairs Correlates with Developmental Co-Expression Patterns</dc:title><dc:creator>Kabir M.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>9</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange/><prism:coverDate>2019-12-01</prism:coverDate><prism:coverDisplayDate>1 December 2019</prism:coverDisplayDate><prism:doi>10.1038/s41598-019-39894-9</prism:doi><dc:description>© 2019, The Author(s). During the evolution of multicellular eukaryotes, gene duplication occurs frequently to generate new genes and/or functions. A duplicated gene may have a similar function to its ancestral gene. Therefore, it may be expected that duplicated genes are less likely to be critical for the survival of an organism, since there are multiple copies of the gene rendering each individual copy redundant. In this study, we explored the developmental expression patterns of duplicate gene pairs and the relationship between development co-expression and phenotypes resulting from the knockout of duplicate genes in the mouse. We define genes that generate lethal phenotypes in single gene knockout experiments as essential genes. We found that duplicate gene pairs comprised of two essential genes tend to be expressed at different stages of development, compared to duplicate gene pairs with at least one non-essential member, showing that the timing of developmental expression affects the ability of one paralogue to compensate for the loss of the other. Gene essentiality, developmental expression and gene duplication are thus closely linked.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60003771</affiliation-url><afid>60003771</afid><affilname>University of Manchester</affilname><affiliation-city>Manchester</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60031101</affiliation-url><afid>60031101</afid><affilname>University of Cambridge</affilname><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60016726</affiliation-url><afid>60016726</afid><affilname>University of Manchester School of Medicine</affilname><affiliation-city>Manchester</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><pubmed-id>30824779</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55513091100</author-url><authid>55513091100</authid><authname>Kabir M.</authname><surname>Kabir</surname><given-name>Mitra</given-name><initials>M.</initials><afid>60003771</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57205170686</author-url><authid>57205170686</authid><authname>Wenlock S.</authname><surname>Wenlock</surname><given-name>Stephanie</given-name><initials>S.</initials><afid>60003771</afid><afid>60031101</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57205170686</author-url><authid>57205170686</authid><authname>Wenlock S.</authname><surname>Wenlock</surname><given-name>Stephanie</given-name><initials>S.</initials><afid>60003771</afid><afid>60031101</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/7004530481</author-url><authid>7004530481</authid><authname>Doig A.</authname><surname>Doig</surname><given-name>Andrew J.</given-name><initials>A.J.</initials><afid>60016726</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/6602603236</author-url><authid>6602603236</authid><authname>Hentges K.</authname><surname>Hentges</surname><given-name>Kathryn E.</given-name><initials>K.E.</initials><afid>60003771</afid></author><article-number>3224</article-number><source-id>21100200805</source-id><fund-no>BB/L018276/1</fund-no><fund-sponsor>Biotechnology and Biological Sciences Research Council</fund-sponsor><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060886129"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060886129?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060886129&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060886129&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060886129</prism:url><dc:identifier>SCOPUS_ID:85060886129</dc:identifier><eid>2-s2.0-85060886129</eid><dc:title>Resistance pattern to macrolides and tetracyclines and detection of ermA, ermB, emrC and mphc genes in clinical isolates of Staphylococcus aureus producing toxic shock syndrome toxin-1</dc:title><dc:creator>Tahmasebi H.</dc:creator><prism:publicationName>Koomesh</prism:publicationName><prism:issn>16087046</prism:issn><prism:volume>21</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>188-194</prism:pageRange><prism:coverDate>2019-12-01</prism:coverDate><prism:coverDisplayDate>1 December 2019</prism:coverDisplayDate><dc:description>© 2019, Semnan University of Medical Sciences. All rights reserved. Introduction: The excessive use of Macrolide-Lincosamide-Streptogramin B (MLSB) to treat infections caused by Staphylococcus aureus (S. aureus,) the producer of toxic shock syndrome toxin-1 (TSST-1), can provide the basis for the emergence of resistant strains. The purpose of this study was to determine the pattern of antibiotic resistance to macrolides and tetracyclines and the genes involved in the occurrence of these resistance in S. aureus strains with TSST-1 toxin. Materials and Methods: In this descriptive cross-sectional study, 113 isolates of S. aureus were studied. Determination of pattern of resistance to macrolides and tetracyclines and different induction phenotypes was performed using disk diffusion method and D test. PCR was used to determine the presence of ermA, ermB, ermC, mphC and tsst gene. Results: Of 113 isolates of S. aureus, 13 isolates (11.5%) were phenotypic D and 11 isolates (9.7%) were a phenotype R. Based on the resistance to clindamycin-erythromycin, 69 isolates (61.66%) were identified as S-phenotype. Tetracycline-resistant isolates (59.29%) had the highest frequency, and isolates resistant to minosilicon, dithromycin and tritromycin had the lowest abundance. In addition, 16 isolates (15.14%) were tst gene, 15 isolates (13.27%) were ermA gene, 6 isolates (5.3%) were ermB gene, 14 isolates (12.38%) were genes ermC and 1 isolate (0.88%) were also carriers of the aphC gene. There was a significant relationship between S. aureus MLSB strains and tst gene presence (p≥0.05). Conclusion: Induced resistance to clindamycin and tetracycline had a significant relationship with the presence of tsst gene in S. aureus strains producing TSST-1 toxin.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60030116</affiliation-url><afid>60030116</afid><affilname>Zahedan University of Medical Sciences</affilname><affiliation-city>Zahedan</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60006672</affiliation-url><afid>60006672</afid><affilname>Hamedan University of Medical Sciences</affilname><affiliation-city>Hamadan</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60006672</affiliation-url><afid>60006672</afid><affilname>Hamedan University of Medical Sciences</affilname><affiliation-city>Hamadan</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/57193276265</author-url><authid>57193276265</authid><authname>Tahmasebi H.</authname><surname>Tahmasebi</surname><given-name>Hamed</given-name><initials>H.</initials><afid>60030116</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57202874206</author-url><authid>57202874206</authid><authname>Dehbashi S.</authname><surname>Dehbashi</surname><given-name>Sanaz</given-name><initials>S.</initials><afid>60006672</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/35344357000</author-url><authid>35344357000</authid><authname>Arabestani M.</authname><surname>Arabestani</surname><given-name>Mohammad Reza</given-name><initials>M.R.</initials><afid>60006672</afid><afid>60006672</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/35344357000</author-url><authid>35344357000</authid><authname>Arabestani M.</authname><surname>Arabestani</surname><given-name>Mohammad Reza</given-name><initials>M.R.</initials><afid>60006672</afid><afid>60006672</afid></author><authkeywords>Antibiotic resistance | ermA gene | ermB gene | Staphylococcus aureus | Toxic shock syndrome toxin-1 | Tsst gene</authkeywords><source-id>19600166219</source-id><fund-no>undefined</fund-no><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060004646"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060004646?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060004646&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060004646&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060004646</prism:url><dc:identifier>SCOPUS_ID:85060004646</dc:identifier><eid>2-s2.0-85060004646</eid><dc:title>Anti-CRISPR-mediated control of gene editing and synthetic circuits in eukaryotic cells</dc:title><dc:creator>Nakamura M.</dc:creator><prism:publicationName>Nature Communications</prism:publicationName><prism:eIssn>20411723</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange/><prism:coverDate>2019-12-01</prism:coverDate><prism:coverDisplayDate>1 December 2019</prism:coverDisplayDate><prism:doi>10.1038/s41467-018-08158-x</prism:doi><dc:description>© 2019, The Author(s). Repurposed CRISPR-Cas molecules provide a useful tool set for broad applications of genomic editing and regulation of gene expression in prokaryotes and eukaryotes. Recent discovery of phage-derived proteins, anti-CRISPRs, which serve to abrogate natural CRISPR anti-phage activity, potentially expands the ability to build synthetic CRISPR-mediated circuits. Here, we characterize a panel of anti-CRISPR molecules for expanded applications to counteract CRISPR-mediated gene activation and repression of reporter and endogenous genes in various cell types. We demonstrate that cells pre-engineered with anti-CRISPR molecules become resistant to gene editing, thus providing a means to generate “write-protected” cells that prevent future gene editing. We further show that anti-CRISPRs can be used to control CRISPR-based gene regulation circuits, including implementation of a pulse generator circuit in mammalian cells. Our work suggests that anti-CRISPR proteins should serve as widely applicable tools for synthetic systems regulating the behavior of eukaryotic cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/122055401</affiliation-url><afid>122055401</afid><affilname>International Christian School</affilname><affiliation-city>Hong Kong</affiliation-city><affiliation-country>Hong Kong</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60023691</affiliation-url><afid>60023691</afid><affilname>University of California, San Francisco</affilname><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60023691</affiliation-url><afid>60023691</afid><affilname>University of California, San Francisco</affilname><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><pubmed-id>30643127</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">30</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55261613000</author-url><authid>55261613000</authid><authname>Nakamura M.</authname><surname>Nakamura</surname><given-name>Muneaki</given-name><initials>M.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55261613000</author-url><authid>55261613000</authid><authname>Nakamura M.</authname><surname>Nakamura</surname><given-name>Muneaki</given-name><initials>M.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55261613000</author-url><authid>55261613000</authid><authname>Nakamura M.</authname><surname>Nakamura</surname><given-name>Muneaki</given-name><initials>M.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57205437967</author-url><authid>57205437967</authid><authname>Srinivasan P.</authname><surname>Srinivasan</surname><given-name>Prashanth</given-name><initials>P.</initials><afid>60012708</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/57205431321</author-url><authid>57205431321</authid><authname>Chavez M.</authname><surname>Chavez</surname><given-name>Michael</given-name><initials>M.</initials><afid>60012708</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57205438758</author-url><authid>57205438758</authid><authname>Carter M.</authname><surname>Carter</surname><given-name>Matthew A.</given-name><initials>M.A.</initials><afid>60012708</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/7203067504</author-url><authid>7203067504</authid><authname>Dominguez A.</authname><surname>Dominguez</surname><given-name>Antonia A.</given-name><initials>A.A.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/7203067504</author-url><authid>7203067504</authid><authname>Dominguez A.</authname><surname>Dominguez</surname><given-name>Antonia A.</given-name><initials>A.A.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/7203067504</author-url><authid>7203067504</authid><authname>Dominguez A.</authname><surname>Dominguez</surname><given-name>Antonia A.</given-name><initials>A.A.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/56481404400</author-url><authid>56481404400</authid><authname>La Russa M.</authname><surname>La Russa</surname><given-name>Marie</given-name><initials>M.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/56481404400</author-url><authid>56481404400</authid><authname>La Russa M.</authname><surname>La Russa</surname><given-name>Marie</given-name><initials>M.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/56481404400</author-url><authid>56481404400</authid><authname>La Russa M.</authname><surname>La Russa</surname><given-name>Marie</given-name><initials>M.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="7"><author-url>https://api.elsevier.com/content/author/author_id/57205445278</author-url><authid>57205445278</authid><authname>Lau M.</authname><surname>Lau</surname><given-name>Matthew B.</given-name><initials>M.B.</initials><afid>60012708</afid><afid>122055401</afid></author><author seq="7"><author-url>https://api.elsevier.com/content/author/author_id/57205445278</author-url><authid>57205445278</authid><authname>Lau M.</authname><surname>Lau</surname><given-name>Matthew B.</given-name><initials>M.B.</initials><afid>60012708</afid><afid>122055401</afid></author><author seq="8"><author-url>https://api.elsevier.com/content/author/author_id/57200007041</author-url><authid>57200007041</authid><authname>Abbott T.</authname><surname>Abbott</surname><given-name>Timothy R.</given-name><initials>T.R.</initials><afid>60012708</afid></author><author seq="9"><author-url>https://api.elsevier.com/content/author/author_id/57202868887</author-url><authid>57202868887</authid><authname>Xu X.</authname><surname>Xu</surname><given-name>Xiaoshu</given-name><initials>X.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="9"><author-url>https://api.elsevier.com/content/author/author_id/57202868887</author-url><authid>57202868887</authid><authname>Xu X.</authname><surname>Xu</surname><given-name>Xiaoshu</given-name><initials>X.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="9"><author-url>https://api.elsevier.com/content/author/author_id/57202868887</author-url><authid>57202868887</authid><authname>Xu X.</authname><surname>Xu</surname><given-name>Xiaoshu</given-name><initials>X.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="10"><author-url>https://api.elsevier.com/content/author/author_id/56829839400</author-url><authid>56829839400</authid><authname>Zhao D.</authname><surname>Zhao</surname><given-name>Dehua</given-name><initials>D.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="10"><author-url>https://api.elsevier.com/content/author/author_id/56829839400</author-url><authid>56829839400</authid><authname>Zhao D.</authname><surname>Zhao</surname><given-name>Dehua</given-name><initials>D.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="10"><author-url>https://api.elsevier.com/content/author/author_id/56829839400</author-url><authid>56829839400</authid><authname>Zhao D.</authname><surname>Zhao</surname><given-name>Dehua</given-name><initials>D.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="11"><author-url>https://api.elsevier.com/content/author/author_id/57191666628</author-url><authid>57191666628</authid><authname>Gao Y.</authname><surname>Gao</surname><given-name>Yuchen</given-name><initials>Y.</initials><afid>60012708</afid><afid>60012708</afid></author><author seq="11"><author-url>https://api.elsevier.com/content/author/author_id/57191666628</author-url><authid>57191666628</authid><authname>Gao Y.</authname><surname>Gao</surname><given-name>Yuchen</given-name><initials>Y.</initials><afid>60012708</afid><afid>60012708</afid></author><author seq="12"><author-url>https://api.elsevier.com/content/author/author_id/57063226400</author-url><authid>57063226400</authid><authname>Kipniss N.</authname><surname>Kipniss</surname><given-name>Nathan H.</given-name><initials>N.H.</initials><afid>60012708</afid></author><author seq="13"><author-url>https://api.elsevier.com/content/author/author_id/6508308176</author-url><authid>6508308176</authid><authname>Smolke C.</authname><surname>Smolke</surname><given-name>Christina D.</given-name><initials>C.D.</initials><afid>60012708</afid></author><author seq="14"><author-url>https://api.elsevier.com/content/author/author_id/23099412700</author-url><authid>23099412700</authid><authname>Bondy-Denomy J.</authname><surname>Bondy-Denomy</surname><given-name>Joseph</given-name><initials>J.</initials><afid>60023691</afid><afid>60023691</afid></author><author seq="14"><author-url>https://api.elsevier.com/content/author/author_id/23099412700</author-url><authid>23099412700</authid><authname>Bondy-Denomy J.</authname><surname>Bondy-Denomy</surname><given-name>Joseph</given-name><initials>J.</initials><afid>60023691</afid><afid>60023691</afid></author><author seq="15"><author-url>https://api.elsevier.com/content/author/author_id/57201488592</author-url><authid>57201488592</authid><authname>Qi L.</authname><surname>Qi</surname><given-name>Lei S.</given-name><initials>L.S.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="15"><author-url>https://api.elsevier.com/content/author/author_id/57201488592</author-url><authid>57201488592</authid><authname>Qi L.</authname><surname>Qi</surname><given-name>Lei S.</given-name><initials>L.S.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="15"><author-url>https://api.elsevier.com/content/author/author_id/57201488592</author-url><authid>57201488592</authid><authname>Qi L.</authname><surname>Qi</surname><given-name>Lei S.</given-name><initials>L.S.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><article-number>194</article-number><source-id>19700182758</source-id><fund-acr>NSF</fund-acr><fund-no>undefined</fund-no><fund-sponsor>Stanford Graduate School of Education</fund-sponsor><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85061395612"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85061395612?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85061395612&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85061395612&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85061395612</prism:url><dc:identifier>SCOPUS_ID:85061395612</dc:identifier><eid>2-s2.0-85061395612</eid><dc:title>Preparation and characterization of PLA-PEG-PLA/PEI/DNA nanoparticles for improvement of transfection efficiency and controlled release of DNA in gene delivery systems</dc:title><dc:creator>Amani A.</dc:creator><prism:publicationName>Iranian Journal of Pharmaceutical Research</prism:publicationName><prism:issn>17350328</prism:issn><prism:eIssn>17266890</prism:eIssn><prism:volume>18</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>125-141</prism:pageRange><prism:coverDate>2019-12-01</prism:coverDate><prism:coverDisplayDate>1 December 2019</prism:coverDisplayDate><dc:description>© 2019, Iranian Journal of Pharmaceutical Research. All rights reserved. Tri-block poly (lactide) poly(ethylene glycol) poly(lactide) (PLA–PEG–PLA) copolymers are among the most attractive nano-carriers for gene delivery into mammalian cells, due to their biocompatibility and biodegradability properties. However, the low efficiency of the gene delivery by these copolymers is an obstacle to gene therapy. Here, we have investigated nanoparticles formulated using the polyethylenimine (PEI) associated with PLA-PEG-PLA copolymer for efficient DNA encapsulation and delivery. PLA-PEG-PLA/DNA and PLA-PEG-PLA/PEI/DNA nanoparticles with different concentrations of PEI were prepared by the double emulsion-solvent evaporation technique. PLA-PEG-PLA/PEI/DNA were characterized for particle size, zeta potential, morphology, biocompatibility, DNA protection, DNA release, and their ability for gene delivery into MCF-7 cells. We found that enhancing the mass ratio of PEI: (PLA-PEG-PLA) (w/w%) in the PLA-PEG-PLA/PEI/DNA nanoparticles results in an increase in particles size, zeta potential, encapsulation efficiency, and DNA release. The electrophoretic analysis confirmed that the PLA-PEG-PLA and PLA-PEG-PLA/PEI could protect DNA from ultrasound damage and nuclease degradation. MTT assay showed that the PLA-PEG-PLA/PEI/DNA had low cytotoxicity than PEI complexes. The potential of PLA-PEG-PLA/PEI/DNA nanoparticles with different concentrations of PEI as a non-viral gene delivery vector for transferring pEGFP-N1 to MCF-7 cells was examined by fluorescent microscopy and flow cytometry. The flow cytometry analysis revealed that by increasing the mass ratio of PEI: (PLA-PEG-PLA) (w/w%) in PLA-PEG-PLA/PEI/DNA nanoparticles, the efficiency of the gene delivery into MCF-7 cells was improved. The results also demonstrated that PLA-PEG-PLA/PEI/DNA nanoparticles in the serum medium improved the efficiency of gene delivery more than two-fold, compared to PEI/DNA complex.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60031210</affiliation-url><afid>60031210</afid><affilname>Tabriz University of Medical Sciences</affilname><affiliation-city>Tabriz</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60022605</affiliation-url><afid>60022605</afid><affilname>University of Mohaghegh Ardebili</affilname><affiliation-city>Ardabil</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60031210</affiliation-url><afid>60031210</afid><affilname>Tabriz University of Medical Sciences</affilname><affiliation-city>Tabriz</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/56290284900</author-url><authid>56290284900</authid><authname>Amani A.</authname><surname>Amani</surname><given-name>Amin</given-name><initials>A.</initials><afid>60031210</afid><afid>60022605</afid></author><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/56290284900</author-url><authid>56290284900</authid><authname>Amani A.</authname><surname>Amani</surname><given-name>Amin</given-name><initials>A.</initials><afid>60031210</afid><afid>60022605</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/57205738122</author-url><authid>57205738122</authid><authname>Kabiri T.</authname><surname>Kabiri</surname><given-name>Toraj</given-name><initials>T.</initials><afid>60022605</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/57194003758</author-url><authid>57194003758</authid><authname>Shafiee S.</authname><surname>Shafiee</surname><given-name>Samira</given-name><initials>S.</initials><afid>60031210</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/23993677200</author-url><authid>23993677200</authid><authname>Hamidi A.</authname><surname>Hamidi</surname><given-name>Aliasghar</given-name><initials>A.</initials><afid>60031210</afid><afid>60031210</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/23993677200</author-url><authid>23993677200</authid><authname>Hamidi A.</authname><surname>Hamidi</surname><given-name>Aliasghar</given-name><initials>A.</initials><afid>60031210</afid><afid>60031210</afid></author><authkeywords>Cytotoxicity | DNA release | Gene delivery | PLA-PEG-PLA | Polyethylenimine</authkeywords><source-id>17700156313</source-id><fund-acr>TUOMS</fund-acr><fund-no>undefined</fund-no><fund-sponsor>Tabriz University of Medical Sciences</fund-sponsor><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85059890207"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85059890207?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85059890207&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85059890207&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85059890207</prism:url><dc:identifier>SCOPUS_ID:85059890207</dc:identifier><eid>2-s2.0-85059890207</eid><dc:title>A gene expression map of shoot domains reveals regulatory mechanisms</dc:title><dc:creator>Tian C.</dc:creator><prism:publicationName>Nature Communications</prism:publicationName><prism:eIssn>20411723</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange/><prism:coverDate>2019-12-01</prism:coverDate><prism:coverDisplayDate>1 December 2019</prism:coverDisplayDate><prism:doi>10.1038/s41467-018-08083-z</prism:doi><dc:description>© 2019, The Author(s). Gene regulatory networks control development via domain-specific gene expression. In seed plants, self-renewing stem cells located in the shoot apical meristem (SAM) produce leaves from the SAM peripheral zone. After initiation, leaves develop polarity patterns to form a planar shape. Here we compare translating RNAs among SAM and leaf domains. Using translating ribosome affinity purification and RNA sequencing to quantify gene expression in target domains, we generate a domain-specific translatome map covering representative vegetative stage SAM and leaf domains. We discuss the predicted cellular functions of these domains and provide evidence that dome seemingly unrelated domains, utilize common regulatory modules. Experimental follow up shows that the RABBIT EARS and HANABA TARANU transcription factors have roles in axillary meristem initiation. This dataset provides a community resource for further study of shoot development and response to internal and environmental signals.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60014277</affiliation-url><afid>60014277</afid><affilname>Institute of Genetics and Developmental Biology Chinese Academy of Sciences</affilname><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60027363</affiliation-url><afid>60027363</afid><affilname>University of Chinese Academy of Sciences</affilname><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60073509</affiliation-url><afid>60073509</afid><affilname>West China Hospital of Sichuan University</affilname><affiliation-city>Chengdu</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60031581</affiliation-url><afid>60031581</afid><affilname>California Institute of Technology</affilname><affiliation-city>Pasadena</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60004630</affiliation-url><afid>60004630</afid><affilname>Fujian Agriculture and Forestry University</affilname><affiliation-city>Fuzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60026383</affiliation-url><afid>60026383</afid><affilname>Sun Yat-Sen University, Zhongshan School of Medicine</affilname><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60005667</affiliation-url><afid>60005667</afid><affilname>Ecole Normale Supérieure de Lyon</affilname><affiliation-city>Lyon</affiliation-city><affiliation-country>France</affiliation-country></affiliation><pubmed-id>30635575</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/22986721200</author-url><authid>22986721200</authid><authname>Tian C.</authname><surname>Tian</surname><given-name>Caihuan</given-name><initials>C.</initials><afid>60014277</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/56118960200</author-url><authid>56118960200</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60027363</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/56241758500</author-url><authid>56241758500</authid><authname>Yu H.</authname><surname>Yu</surname><given-name>Haopeng</given-name><initials>H.</initials><afid>60014277</afid><afid>60027363</afid><afid>60073509</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/56241758500</author-url><authid>56241758500</authid><authname>Yu H.</authname><surname>Yu</surname><given-name>Haopeng</given-name><initials>H.</initials><afid>60014277</afid><afid>60027363</afid><afid>60073509</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/56241758500</author-url><authid>56241758500</authid><authname>Yu H.</authname><surname>Yu</surname><given-name>Haopeng</given-name><initials>H.</initials><afid>60014277</afid><afid>60027363</afid><afid>60073509</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/56118930000</author-url><authid>56118930000</authid><authname>He J.</authname><surname>He</surname><given-name>Jun</given-name><initials>J.</initials><afid>60014277</afid><afid>60004630</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/56118930000</author-url><authid>56118930000</authid><authname>He J.</authname><surname>He</surname><given-name>Jun</given-name><initials>J.</initials><afid>60014277</afid><afid>60004630</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/56189279900</author-url><authid>56189279900</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jin</given-name><initials>J.</initials><afid>60014277</afid><afid>60027363</afid><afid>60026383</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/56189279900</author-url><authid>56189279900</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jin</given-name><initials>J.</initials><afid>60014277</afid><afid>60027363</afid><afid>60026383</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/56189279900</author-url><authid>56189279900</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jin</given-name><initials>J.</initials><afid>60014277</afid><afid>60027363</afid><afid>60026383</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/56242144800</author-url><authid>56242144800</authid><authname>Shi B.</authname><surname>Shi</surname><given-name>Bihai</given-name><initials>B.</initials><afid>60014277</afid><afid>60027363</afid><afid>60005667</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/56242144800</author-url><authid>56242144800</authid><authname>Shi B.</authname><surname>Shi</surname><given-name>Bihai</given-name><initials>B.</initials><afid>60014277</afid><afid>60027363</afid><afid>60005667</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/56242144800</author-url><authid>56242144800</authid><authname>Shi B.</authname><surname>Shi</surname><given-name>Bihai</given-name><initials>B.</initials><afid>60014277</afid><afid>60027363</afid><afid>60005667</afid></author><author seq="7"><author-url>https://api.elsevier.com/content/author/author_id/57205406803</author-url><authid>57205406803</authid><authname>Du Q.</authname><surname>Du</surname><given-name>Qingwei</given-name><initials>Q.</initials><afid>60014277</afid><afid>60027363</afid></author><author seq="7"><author-url>https://api.elsevier.com/content/author/author_id/57205406803</author-url><authid>57205406803</authid><authname>Du Q.</authname><surname>Du</surname><given-name>Qingwei</given-name><initials>Q.</initials><afid>60014277</afid><afid>60027363</afid></author><author seq="8"><author-url>https://api.elsevier.com/content/author/author_id/6602822348</author-url><authid>6602822348</authid><authname>Provart N.</authname><surname>Provart</surname><given-name>Nicholas J.</given-name><initials>N.J.</initials><afid>60016849</afid></author><author seq="9"><author-url>https://api.elsevier.com/content/author/author_id/57200302234</author-url><authid>57200302234</authid><authname>Meyerowitz E.</authname><surname>Meyerowitz</surname><given-name>Elliot M.</given-name><initials>E.M.</initials><afid>60031581</afid></author><author seq="10"><author-url>https://api.elsevier.com/content/author/author_id/57205110179</author-url><authid>57205110179</authid><authname>Jiao Y.</authname><surname>Jiao</surname><given-name>Yuling</given-name><initials>Y.</initials><afid>60014277</afid><afid>60027363</afid></author><author seq="10"><author-url>https://api.elsevier.com/content/author/author_id/57205110179</author-url><authid>57205110179</authid><authname>Jiao Y.</authname><surname>Jiao</surname><given-name>Yuling</given-name><initials>Y.</initials><afid>60014277</afid><afid>60027363</afid></author><article-number>141</article-number><source-id>19700182758</source-id><fund-no>undefined</fund-no><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060547867"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060547867?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060547867&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060547867&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060547867</prism:url><dc:identifier>SCOPUS_ID:85060547867</dc:identifier><eid>2-s2.0-85060547867</eid><dc:title>AAV2.7m8 is a powerful viral vector for inner ear gene therapy</dc:title><dc:creator>Isgrig K.</dc:creator><prism:publicationName>Nature Communications</prism:publicationName><prism:eIssn>20411723</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange/><prism:coverDate>2019-12-01</prism:coverDate><prism:coverDisplayDate>1 December 2019</prism:coverDisplayDate><prism:doi>10.1038/s41467-018-08243-1</prism:doi><dc:description>© 2019, The Author(s). Adeno-associated virus (AAV) has been successfully used to deliver gene therapy to improve auditory function in mouse models of hereditary hearing loss. Many forms of hereditary hearing loss have mutations which affect the cochlear hair cells, the mechanosensory cells which allow for sound detection and processing. While most conventional AAVs infect inner hair cells (IHCs) with various efficiencies, they infect outer hair cells (OHCs) and supporting cells at lower levels in the cochlea. Here we examine the infection patterns of two synthetic AAVs (AAV2.7m8 and AAV8BP2) in the mouse inner ear. AAV2.7m8 infects both IHCs and OHCs with high efficiency. In addition, AAV2.7m8 infects inner pillar cells and inner phalangeal cells with high efficiency. Our results suggest that AAV2.7m8 is an excellent viral vector for inner ear gene therapy targeting cochlear hair cells and supporting cells, and it will likely greatly expand the potential applications for inner ear gene therapy.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60013123</affiliation-url><afid>60013123</afid><affilname>National Institute on Deafness and Other Communication Disorders</affilname><affiliation-city>Bethesda</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60006297</affiliation-url><afid>60006297</afid><affilname>University of Pennsylvania</affilname><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60001117</affiliation-url><afid>60001117</afid><affilname>The Johns Hopkins School of Medicine</affilname><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><pubmed-id>30683875</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/56835688400</author-url><authid>56835688400</authid><authname>Isgrig K.</authname><surname>Isgrig</surname><given-name>Kevin</given-name><initials>K.</initials><afid>60013123</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/56336951800</author-url><authid>56336951800</authid><authname>McDougald D.</authname><surname>McDougald</surname><given-name>Devin S.</given-name><initials>D.S.</initials><afid>60006297</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/57205560829</author-url><authid>57205560829</authid><authname>Zhu J.</authname><surname>Zhu</surname><given-name>Jianliang</given-name><initials>J.</initials><afid>60013123</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57205560995</author-url><authid>57205560995</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Hong Jun</given-name><initials>H.J.</initials><afid>60013123</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/7404251252</author-url><authid>7404251252</authid><authname>Bennett J.</authname><surname>Bennett</surname><given-name>Jean</given-name><initials>J.</initials><afid>60006297</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/13006881600</author-url><authid>13006881600</authid><authname>Chien W.</authname><surname>Chien</surname><given-name>Wade W.</given-name><initials>W.W.</initials><afid>60013123</afid><afid>60001117</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/13006881600</author-url><authid>13006881600</authid><authname>Chien W.</authname><surname>Chien</surname><given-name>Wade W.</given-name><initials>W.W.</initials><afid>60013123</afid><afid>60001117</afid></author><article-number>427</article-number><source-id>19700182758</source-id><fund-acr>RPB</fund-acr><fund-no>R21EY020662</fund-no><fund-sponsor>Research to Prevent Blindness</fund-sponsor><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85060379712"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85060379712?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85060379712&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85060379712&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85060379712</prism:url><dc:identifier>SCOPUS_ID:85060379712</dc:identifier><eid>2-s2.0-85060379712</eid><dc:title>Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer</dc:title><dc:creator>Annunziato S.</dc:creator><prism:publicationName>Nature Communications</prism:publicationName><prism:eIssn>20411723</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange/><prism:coverDate>2019-12-01</prism:coverDate><prism:coverDisplayDate>1 December 2019</prism:coverDisplayDate><prism:doi>10.1038/s41467-019-08301-2</prism:doi><dc:description>© 2019, The Author(s). BRCA1-mutated breast cancer is primarily driven by DNA copy-number alterations (CNAs) containing large numbers of candidate driver genes. Validation of these candidates requires novel approaches for high-throughput in vivo perturbation of gene function. Here we develop genetically engineered mouse models (GEMMs) of BRCA1-deficient breast cancer that permit rapid introduction of putative drivers by either retargeting of GEMM-derived embryonic stem cells, lentivirus-mediated somatic overexpression or in situ CRISPR/Cas9-mediated gene disruption. We use these approaches to validate Myc, Met, Pten and Rb1 as bona fide drivers in BRCA1-associated mammary tumorigenesis. Iterative mouse modeling and comparative oncogenomics analysis show that MYC-overexpression strongly reshapes the CNA landscape of BRCA1-deficient mammary tumors and identify MCL1 as a collaborating driver in these tumors. Moreover, MCL1 inhibition potentiates the in vivo efficacy of PARP inhibition (PARPi), underscoring the therapeutic potential of this combination for treatment of BRCA1-mutated cancer patients with poor response to PARPi monotherapy.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60015205</affiliation-url><afid>60015205</afid><affilname>The Netherlands Cancer Institute</affilname><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60015205</affiliation-url><afid>60015205</afid><affilname>The Netherlands Cancer Institute</affilname><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60015205</affiliation-url><afid>60015205</afid><affilname>The Netherlands Cancer Institute</affilname><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60015205</affiliation-url><afid>60015205</afid><affilname>The Netherlands Cancer Institute</affilname><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60015205</affiliation-url><afid>60015205</afid><affilname>The Netherlands Cancer Institute</affilname><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60027468</affiliation-url><afid>60027468</afid><affilname>Walter and Eliza Hall Institute of Medical Research</affilname><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60026553</affiliation-url><afid>60026553</afid><affilname>University of Melbourne</affilname><affiliation-city>Parkville</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60015205</affiliation-url><afid>60015205</afid><affilname>The Netherlands Cancer Institute</affilname><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/120287459</affiliation-url><afid>120287459</afid><affilname>University of Medicine</affilname><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60033129</affiliation-url><afid>60033129</afid><affilname>Peter Maccallum Cancer Centre</affilname><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><pubmed-id>30674894</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">48</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55901602000</author-url><authid>55901602000</authid><authname>Annunziato S.</authname><surname>Annunziato</surname><given-name>Stefano</given-name><initials>S.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55901602000</author-url><authid>55901602000</authid><authname>Annunziato S.</authname><surname>Annunziato</surname><given-name>Stefano</given-name><initials>S.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/55901602000</author-url><authid>55901602000</authid><authname>Annunziato S.</authname><surname>Annunziato</surname><given-name>Stefano</given-name><initials>S.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/56779771900</author-url><authid>56779771900</authid><authname>de Ruiter J.</authname><surname>de Ruiter</surname><given-name>Julian R.</given-name><initials>J.R.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/56779771900</author-url><authid>56779771900</authid><authname>de Ruiter J.</authname><surname>de Ruiter</surname><given-name>Julian R.</given-name><initials>J.R.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/56779771900</author-url><authid>56779771900</authid><authname>de Ruiter J.</authname><surname>de Ruiter</surname><given-name>Julian R.</given-name><initials>J.R.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/56779771900</author-url><authid>56779771900</authid><authname>de Ruiter J.</authname><surname>de Ruiter</surname><given-name>Julian R.</given-name><initials>J.R.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/56715453600</author-url><authid>56715453600</authid><authname>Henneman L.</authname><surname>Henneman</surname><given-name>Linda</given-name><initials>L.</initials><afid>60015205</afid><afid>60015205</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/56715453600</author-url><authid>56715453600</authid><authname>Henneman L.</authname><surname>Henneman</surname><given-name>Linda</given-name><initials>L.</initials><afid>60015205</afid><afid>60015205</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57205525169</author-url><authid>57205525169</authid><authname>Brambillasca C.</authname><surname>Brambillasca</surname><given-name>Chiara S.</given-name><initials>C.S.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57205525169</author-url><authid>57205525169</authid><authname>Brambillasca C.</authname><surname>Brambillasca</surname><given-name>Chiara S.</given-name><initials>C.S.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57205525169</author-url><authid>57205525169</authid><authname>Brambillasca C.</authname><surname>Brambillasca</surname><given-name>Chiara S.</given-name><initials>C.S.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/57201974420</author-url><authid>57201974420</authid><authname>Lutz C.</authname><surname>Lutz</surname><given-name>Catrin</given-name><initials>C.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/57201974420</author-url><authid>57201974420</authid><authname>Lutz C.</authname><surname>Lutz</surname><given-name>Catrin</given-name><initials>C.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="5"><author-url>https://api.elsevier.com/content/author/author_id/57201974420</author-url><authid>57201974420</authid><authname>Lutz C.</authname><surname>Lutz</surname><given-name>Catrin</given-name><initials>C.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/7003387056</author-url><authid>7003387056</authid><authname>Vaillant F.</authname><surname>Vaillant</surname><given-name>François</given-name><initials>F.</initials><afid>60027468</afid><afid>60026553</afid></author><author seq="6"><author-url>https://api.elsevier.com/content/author/author_id/7003387056</author-url><authid>7003387056</authid><authname>Vaillant F.</authname><surname>Vaillant</surname><given-name>François</given-name><initials>F.</initials><afid>60027468</afid><afid>60026553</afid></author><author seq="7"><author-url>https://api.elsevier.com/content/author/author_id/57205532207</author-url><authid>57205532207</authid><authname>Ferrante F.</authname><surname>Ferrante</surname><given-name>Federica</given-name><initials>F.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="7"><author-url>https://api.elsevier.com/content/author/author_id/57205532207</author-url><authid>57205532207</authid><authname>Ferrante F.</authname><surname>Ferrante</surname><given-name>Federica</given-name><initials>F.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="7"><author-url>https://api.elsevier.com/content/author/author_id/57205532207</author-url><authid>57205532207</authid><authname>Ferrante F.</authname><surname>Ferrante</surname><given-name>Federica</given-name><initials>F.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="8"><author-url>https://api.elsevier.com/content/author/author_id/56715470500</author-url><authid>56715470500</authid><authname>Drenth A.</authname><surname>Drenth</surname><given-name>Anne Paulien</given-name><initials>A.P.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="8"><author-url>https://api.elsevier.com/content/author/author_id/56715470500</author-url><authid>56715470500</authid><authname>Drenth A.</authname><surname>Drenth</surname><given-name>Anne Paulien</given-name><initials>A.P.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="8"><author-url>https://api.elsevier.com/content/author/author_id/56715470500</author-url><authid>56715470500</authid><authname>Drenth A.</authname><surname>Drenth</surname><given-name>Anne Paulien</given-name><initials>A.P.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="9"><author-url>https://api.elsevier.com/content/author/author_id/24923593400</author-url><authid>24923593400</authid><authname>van der Burg E.</authname><surname>van der Burg</surname><given-name>Eline</given-name><initials>E.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="9"><author-url>https://api.elsevier.com/content/author/author_id/24923593400</author-url><authid>24923593400</authid><authname>van der Burg E.</authname><surname>van der Burg</surname><given-name>Eline</given-name><initials>E.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="9"><author-url>https://api.elsevier.com/content/author/author_id/24923593400</author-url><authid>24923593400</authid><authname>van der Burg E.</authname><surname>van der Burg</surname><given-name>Eline</given-name><initials>E.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="10"><author-url>https://api.elsevier.com/content/author/author_id/57127238400</author-url><authid>57127238400</authid><authname>Siteur B.</authname><surname>Siteur</surname><given-name>Bjørn</given-name><initials>B.</initials><afid>60015205</afid></author><author seq="11"><author-url>https://api.elsevier.com/content/author/author_id/56397067100</author-url><authid>56397067100</authid><authname>van Gerwen B.</authname><surname>van Gerwen</surname><given-name>Bas</given-name><initials>B.</initials><afid>60015205</afid></author><author seq="12"><author-url>https://api.elsevier.com/content/author/author_id/57202354808</author-url><authid>57202354808</authid><authname>de Bruijn R.</authname><surname>de Bruijn</surname><given-name>Roebi</given-name><initials>R.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="12"><author-url>https://api.elsevier.com/content/author/author_id/57202354808</author-url><authid>57202354808</authid><authname>de Bruijn R.</authname><surname>de Bruijn</surname><given-name>Roebi</given-name><initials>R.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="12"><author-url>https://api.elsevier.com/content/author/author_id/57202354808</author-url><authid>57202354808</authid><authname>de Bruijn R.</authname><surname>de Bruijn</surname><given-name>Roebi</given-name><initials>R.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="12"><author-url>https://api.elsevier.com/content/author/author_id/57202354808</author-url><authid>57202354808</authid><authname>de Bruijn R.</authname><surname>de Bruijn</surname><given-name>Roebi</given-name><initials>R.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="13"><author-url>https://api.elsevier.com/content/author/author_id/7801560953</author-url><authid>7801560953</authid><authname>van Miltenburg M.</authname><surname>van Miltenburg</surname><given-name>Martine H.</given-name><initials>M.H.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="13"><author-url>https://api.elsevier.com/content/author/author_id/7801560953</author-url><authid>7801560953</authid><authname>van Miltenburg M.</authname><surname>van Miltenburg</surname><given-name>Martine H.</given-name><initials>M.H.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="13"><author-url>https://api.elsevier.com/content/author/author_id/7801560953</author-url><authid>7801560953</authid><authname>van Miltenburg M.</authname><surname>van Miltenburg</surname><given-name>Martine H.</given-name><initials>M.H.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="14"><author-url>https://api.elsevier.com/content/author/author_id/7801459396</author-url><authid>7801459396</authid><authname>Huijbers I.</authname><surname>Huijbers</surname><given-name>Ivo J.</given-name><initials>I.J.</initials><afid>60015205</afid></author><author seq="15"><author-url>https://api.elsevier.com/content/author/author_id/15043433900</author-url><authid>15043433900</authid><authname>van de Ven M.</authname><surname>van de Ven</surname><given-name>Marieke</given-name><initials>M.</initials><afid>60015205</afid></author><author seq="16"><author-url>https://api.elsevier.com/content/author/author_id/7003366047</author-url><authid>7003366047</authid><authname>Visvader J.</authname><surname>Visvader</surname><given-name>Jane E.</given-name><initials>J.E.</initials><afid>60027468</afid><afid>60026553</afid></author><author seq="16"><author-url>https://api.elsevier.com/content/author/author_id/7003366047</author-url><authid>7003366047</authid><authname>Visvader J.</authname><surname>Visvader</surname><given-name>Jane E.</given-name><initials>J.E.</initials><afid>60027468</afid><afid>60026553</afid></author><author seq="17"><author-url>https://api.elsevier.com/content/author/author_id/57202571369</author-url><authid>57202571369</authid><authname>Lindeman G.</authname><surname>Lindeman</surname><given-name>Geoffrey J.</given-name><initials>G.J.</initials><afid>60027468</afid><afid>120287459</afid><afid>60033129</afid></author><author seq="17"><author-url>https://api.elsevier.com/content/author/author_id/57202571369</author-url><authid>57202571369</authid><authname>Lindeman G.</authname><surname>Lindeman</surname><given-name>Geoffrey J.</given-name><initials>G.J.</initials><afid>60027468</afid><afid>120287459</afid><afid>60033129</afid></author><author seq="17"><author-url>https://api.elsevier.com/content/author/author_id/57202571369</author-url><authid>57202571369</authid><authname>Lindeman G.</authname><surname>Lindeman</surname><given-name>Geoffrey J.</given-name><initials>G.J.</initials><afid>60027468</afid><afid>120287459</afid><afid>60033129</afid></author><author seq="18"><author-url>https://api.elsevier.com/content/author/author_id/6603692712</author-url><authid>6603692712</authid><authname>Wessels L.</authname><surname>Wessels</surname><given-name>Lodewyk F.A.</given-name><initials>L.F.A.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="18"><author-url>https://api.elsevier.com/content/author/author_id/6603692712</author-url><authid>6603692712</authid><authname>Wessels L.</authname><surname>Wessels</surname><given-name>Lodewyk F.A.</given-name><initials>L.F.A.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="18"><author-url>https://api.elsevier.com/content/author/author_id/6603692712</author-url><authid>6603692712</authid><authname>Wessels L.</authname><surname>Wessels</surname><given-name>Lodewyk F.A.</given-name><initials>L.F.A.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="19"><author-url>https://api.elsevier.com/content/author/author_id/55572496500</author-url><authid>55572496500</authid><authname>Jonkers J.</authname><surname>Jonkers</surname><given-name>Jos</given-name><initials>J.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="19"><author-url>https://api.elsevier.com/content/author/author_id/55572496500</author-url><authid>55572496500</authid><authname>Jonkers J.</authname><surname>Jonkers</surname><given-name>Jos</given-name><initials>J.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><author seq="19"><author-url>https://api.elsevier.com/content/author/author_id/55572496500</author-url><authid>55572496500</authid><authname>Jonkers J.</authname><surname>Jonkers</surname><given-name>Jos</given-name><initials>J.</initials><afid>60015205</afid><afid>60015205</afid><afid>60015205</afid></author><article-number>397</article-number><source-id>19700182758</source-id><fund-acr>NGI</fund-acr><fund-no>93512009</fund-no><fund-sponsor>Northern Gulf Institute</fund-sponsor><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85059589988"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85059589988?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85059589988&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85059589988&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85059589988</prism:url><dc:identifier>SCOPUS_ID:85059589988</dc:identifier><eid>2-s2.0-85059589988</eid><dc:title>Identification of target genes in cancer diseases using protein–protein interaction networks</dc:title><dc:creator>Amala A.</dc:creator><prism:publicationName>Network Modeling Analysis in Health Informatics and Bioinformatics</prism:publicationName><prism:issn>21926662</prism:issn><prism:eIssn>21926670</prism:eIssn><prism:volume>8</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange/><prism:coverDate>2019-12-01</prism:coverDate><prism:coverDisplayDate>1 December 2019</prism:coverDisplayDate><prism:doi>10.1007/s13721-018-0181-1</prism:doi><dc:description>© 2019, Springer-Verlag GmbH Austria, part of Springer Nature. Cancer is a disease that is characterized by uncontrolled cell growth with the ability to penetrate or develop to the other parts of the body. Various studies have shown the significance of identifying drug targets for cancer, although this process continues challenging in the field of anti-cancer drug designing. The primary purpose of this study is to design a novel approach to identify target genes for cancer. The sub-network of colorectal, pancreatic, and prostate cancers were constructed from human protein–protein interaction network. The potential genes were analyzed using hubs and centrality measures. For the identification of target genes, we retrieve those genes that had the highest score in both mutation rates and graph centrality. Moreover, gene deletion analysis revealed that MYC, TP53, and EGFR genes remained potential targets in colorectal, pancreatic, and prostate cancer respectively. Results suggest that combining network measures with mutation frequencies in cancer genes might assist in recognizing several potential drug targets. Future enhancement of this current approach is to combine these network properties with the biological insights from gene expression data, and their functions will provide a reliable method for rational drug designing.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60010618</affiliation-url><afid>60010618</afid><affilname>Vellore Institute of Technology</affilname><affiliation-city>Vellore</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/57191196061</author-url><authid>57191196061</authid><authname>Amala A.</authname><surname>Amala</surname><given-name>Arumugam</given-name><initials>A.</initials><afid>60010618</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/54398356900</author-url><authid>54398356900</authid><authname>Emerson I.</authname><surname>Emerson</surname><given-name>Isaac Arnold</given-name><initials>I.A.</initials><afid>60010618</afid></author><authkeywords>Cancer | Centrality | Hubs | Network topology</authkeywords><article-number>2</article-number><source-id>21100781975</source-id><fund-no>undefined</fund-no><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag></entry><entry><link ref="self" href="https://api.elsevier.com/content/abstract/scopus_id/85062418124"/><link ref="author-affiliation" href="https://api.elsevier.com/content/abstract/scopus_id/85062418124?field=author,affiliation"/><link ref="scopus" href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85062418124&amp;origin=inward"/><link ref="scopus-citedby" href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85062418124&amp;origin=inward"/><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85062418124</prism:url><dc:identifier>SCOPUS_ID:85062418124</dc:identifier><eid>2-s2.0-85062418124</eid><dc:title>Assessing Sus scrofa diversity among continental United States, and Pacific islands populations using molecular markers from a gene banks collection</dc:title><dc:creator>Faria D.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>9</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange/><prism:coverDate>2019-12-01</prism:coverDate><prism:coverDisplayDate>1 December 2019</prism:coverDisplayDate><prism:doi>10.1038/s41598-019-39309-9</prism:doi><dc:description>© 2019, The Author(s).  Human migration and trade facilitated domesticated livestock movement, gene flow and development of diverse populations upon which agriculture is based. In addition, varying USA ecological conditions has led to a diverse set of livestock populations to utilize. Quantifying genetic diversity of these populations is incomplete. This paper quantifies genetic diversity captured by the National Animal Germplasm Program and explores genetic structure and differences among 19 pig populations (feral populations from Pacific islands, continental US, and Chinese breeds) using 70,231 SNP from 500 animal samples. Among continental US breeds F is was consistently low suggesting genetic variability is sufficiently available for breeders to use. A unique population structure using principal component analysis illustrated clear distinctions between Duroc, Yorkshire, Hampshire, breeds of Chinese origin, and feral Pacific Island populations were identified. Five Y chromosome haplotypes were evaluated and demonstrated migration patterns from European, central Asia, and potentially Polynesian waves of gene flow. Quantifying diversity and potential origin of Pacific populations provides insight for future uses, and the need for preservation. Viewing gene bank holdings in context of diversity measures we found a lack of inbreeding within breeds, suggesting the collection represents a wide sampling of individual breeds.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60024989</affiliation-url><afid>60024989</afid><affilname>Universidade de Brasília</affilname><affiliation-city>Brasilia</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/60001989</affiliation-url><afid>60001989</afid><affilname>USDA Agricultural Research Service, Washington DC</affilname><affiliation-city>Washington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>https://api.elsevier.com/content/affiliation/affiliation_id/120345563</affiliation-url><afid>120345563</afid><affilname>Embrapa Recursos Genéticos e Biotecnologia</affilname><affiliation-city>Brasilia</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><pubmed-id>30816173</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/24178241400</author-url><authid>24178241400</authid><authname>Faria D.</authname><surname>Faria</surname><given-name>D. A.</given-name><initials>D.A.</initials><afid>60024989</afid><afid>60001989</afid></author><author seq="1"><author-url>https://api.elsevier.com/content/author/author_id/24178241400</author-url><authid>24178241400</authid><authname>Faria D.</authname><surname>Faria</surname><given-name>D. A.</given-name><initials>D.A.</initials><afid>60024989</afid><afid>60001989</afid></author><author seq="2"><author-url>https://api.elsevier.com/content/author/author_id/56416604300</author-url><authid>56416604300</authid><authname>Wilson C.</authname><surname>Wilson</surname><given-name>C.</given-name><initials>C.</initials><afid>60001989</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/8380019100</author-url><authid>8380019100</authid><authname>Paiva S.</authname><surname>Paiva</surname><given-name>Samuel</given-name><initials>S.</initials><afid>60001989</afid><afid>120345563</afid></author><author seq="3"><author-url>https://api.elsevier.com/content/author/author_id/8380019100</author-url><authid>8380019100</authid><authname>Paiva S.</authname><surname>Paiva</surname><given-name>Samuel</given-name><initials>S.</initials><afid>60001989</afid><afid>120345563</afid></author><author seq="4"><author-url>https://api.elsevier.com/content/author/author_id/57204327520</author-url><authid>57204327520</authid><authname>Blackburn H.</authname><surname>Blackburn</surname><given-name>H. D.</given-name><initials>H.D.</initials><afid>60001989</afid></author><article-number>3173</article-number><source-id>21100200805</source-id><fund-no>undefined</fund-no><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag></entry></search-results>